content: <?xml version="1.0" encoding="utf-8"?>
  <html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:aaciu="http://armadaacq.com/20210630">
  <head>
       <title></title>
  <meta http-equiv="Content-Type" content="text/html" />
  </head>
  <!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
  <!-- Field: Set; Name: xdx; ID: xdx_032_aaciu_armadaacq.com_20210630 -->
  <!-- Field: Set; Name: xdx; ID: xdx_04D_20201106_20210630 -->
  <!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001844817 -->
  <!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
  <!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DDocumentFiscalPeriodFocus_Q3 -->
  <!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DDocumentFiscalYearFocus_2021 -->
  <!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0wOS0zMA== -->
  <!-- Field: Set; Name: xdx; ID: xdx_073_XDX_aaciu10q.xdx -->
  <!-- Field: Set; Name: xdx; ID: xdx_076_SO_aaciu10q.xdxs -->
  <!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
  <!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
  <!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
  <!-- Field: Set; Name: xdx; ID: xdx_065_Pure_0_xbrli%2D%2Dpure -->
  <!-- Field: Set; Name: xdx; ID: xdx_063_Director_0_Director -->
  <!-- Field: Set; Name: xdx; ID: xdx_06B_Investor_0_Investor -->
  <body style="font: 10pt Times New Roman, Times, Serif">
  <div style="display: none">
  <ix:header>
   <ix:hidden>
    <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" name="dei:EntityCentralIndexKey">0001844817</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" name="dei:DocumentFiscalPeriodFocus">Q3</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" name="dei:DocumentFiscalYearFocus">2021</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" name="dei:CurrentFiscalYearEndDate">--09-30</ix:nonNumeric>
    <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2021-06-30" id="xdx2ixbrl0070" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-06-30" id="xdx2ixbrl0074" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-11-05_us-gaap_CommonStockMember" id="xdx2ixbrl0122" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-11-05_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0123" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-11-05_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0124" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-11-05" id="xdx2ixbrl0125" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2020-11-05_us-gaap_CommonStockMember" id="xdx2ixbrl0127" unitRef="Shares" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-11-062021-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0131" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2020-11-062021-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0138" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2020-11-062021-03-31" id="xdx2ixbrl0139" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-062021-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0143" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-062021-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0144" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0156" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="From2021-04-012021-06-30" id="xdx2ixbrl0157" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0165" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0173" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0174" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2020-11-05" id="xdx2ixbrl0213" unitRef="USD" xs:nil="true"></ix:nonFraction>
    </ix:hidden>
   <ix:references>
    <link:schemaRef xlink:href="aaciu-20210630.xsd" xlink:type="simple" />
    </ix:references>
   <ix:resources>
      <xbrli:context id="From2020-11-06to2021-06-30">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2020-11-06</xbrli:startDate>
          <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2020-11-062021-06-30_custom_UnitsEachConsistingOfOneShareOfCommonStockAndOnehalfOfOneRedeemableWarrantMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:UnitsEachConsistingOfOneShareOfCommonStockAndOnehalfOfOneRedeemableWarrantMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2020-11-06</xbrli:startDate>
          <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2020-11-062021-06-30_custom_CommonStockParValue0.0001PerShareMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2020-11-06</xbrli:startDate>
          <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2020-11-062021-06-30_custom_WarrantsEachExercisableForOneShareOfCommonStockFor11.50PerShareMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:WarrantsEachExercisableForOneShareOfCommonStockFor11.50PerShareMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2020-11-06</xbrli:startDate>
          <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-09-27">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-09-27</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-06-30">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-06-30</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-04-012021-06-30">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-04-01</xbrli:startDate>
          <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2020-11-05_us-gaap_CommonStockMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2020-11-05</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2020-11-05_us-gaap_AdditionalPaidInCapitalMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2020-11-05</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2020-11-05_us-gaap_RetainedEarningsMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2020-11-05</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2020-11-05">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2020-11-05</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2020-11-062021-03-31_us-gaap_CommonStockMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2020-11-06</xbrli:startDate>
          <xbrli:endDate>2021-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2020-11-062021-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2020-11-06</xbrli:startDate>
          <xbrli:endDate>2021-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2020-11-062021-03-31_us-gaap_RetainedEarningsMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2020-11-06</xbrli:startDate>
          <xbrli:endDate>2021-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2020-11-062021-03-31">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2020-11-06</xbrli:startDate>
          <xbrli:endDate>2021-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-03-31_us-gaap_CommonStockMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-03-31">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-04-012021-06-30_us-gaap_CommonStockMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-04-01</xbrli:startDate>
          <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-04-01</xbrli:startDate>
          <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-04-01</xbrli:startDate>
          <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-06-30_us-gaap_CommonStockMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-06-30</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-06-30</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-06-30</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_us-gaap_IPOMember_custom_UnitsMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:UnitsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-08-16</xbrli:startDate>
          <xbrli:endDate>2021-08-17</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-08-17_us-gaap_SubsequentEventMember_us-gaap_IPOMember_custom_UnitsMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:UnitsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-08-17</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_PrivateSharesMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:PrivateSharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-08-16</xbrli:startDate>
          <xbrli:endDate>2021-08-17</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-08-17_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_PrivateSharesMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:PrivateSharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-08-17</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-08-162021-08-17_us-gaap_SubsequentEventMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-08-16</xbrli:startDate>
          <xbrli:endDate>2021-08-17</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-08-17_us-gaap_SubsequentEventMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-08-17</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-08-18_us-gaap_SubsequentEventMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-08-18</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-06-152021-06-16_srt_ChiefExecutiveOfficerMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-06-15</xbrli:startDate>
          <xbrli:endDate>2021-06-16</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-06-152021-06-16_srt_PresidentMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:PresidentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-06-15</xbrli:startDate>
          <xbrli:endDate>2021-06-16</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-06-152021-06-16_srt_DirectorMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-06-15</xbrli:startDate>
          <xbrli:endDate>2021-06-16</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-06-152021-06-30">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-06-15</xbrli:startDate>
          <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-02-022021-02-03_custom_FounderSharesMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:FounderSharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-02-02</xbrli:startDate>
          <xbrli:endDate>2021-02-03</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-02-03_custom_FounderSharesMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:FounderSharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-02-03</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-06-152021-06-16_custom_FounderSharesMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:FounderSharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-06-15</xbrli:startDate>
          <xbrli:endDate>2021-06-16</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-06-16_custom_FounderSharesMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:FounderSharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-06-16</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2020-11-062021-06-30_custom_FounderSharesMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:FounderSharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2020-11-06</xbrli:startDate>
          <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_custom_UnitsMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:UnitsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-08-16</xbrli:startDate>
          <xbrli:endDate>2021-08-17</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_custom_FounderSharesMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:FounderSharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-08-16</xbrli:startDate>
          <xbrli:endDate>2021-08-17</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-08-17_us-gaap_SubsequentEventMember_custom_FounderSharesMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:FounderSharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-08-17</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-02-072021-02-08_custom_RepresentativeSharesMember_custom_EarlyBirdCapitalIncMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:RepresentativeSharesMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">aaciu:EarlyBirdCapitalIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-02-07</xbrli:startDate>
          <xbrli:endDate>2021-02-08</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-02-072021-02-08_custom_RepresentativeSharesMember_custom_NorthlandSecuritiesIncMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:RepresentativeSharesMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">aaciu:NorthlandSecuritiesIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-02-07</xbrli:startDate>
          <xbrli:endDate>2021-02-08</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-02-08_custom_RepresentativeSharesMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:RepresentativeSharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-02-08</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-02-072021-02-08_custom_RepresentativeSharesMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:RepresentativeSharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-02-07</xbrli:startDate>
          <xbrli:endDate>2021-02-08</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-05-282021-05-29_custom_RepresentativeSharesMember_custom_NorthlandSecuritiesIncMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:RepresentativeSharesMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">aaciu:NorthlandSecuritiesIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-05-28</xbrli:startDate>
          <xbrli:endDate>2021-05-29</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2020-11-062021-06-30_custom_RepresentativeSharesMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:RepresentativeSharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2020-11-06</xbrli:startDate>
          <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-02-03_custom_SponsorMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aaciu:SponsorMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-02-03</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-06-292021-06-30_custom_SponsorMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aaciu:SponsorMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-06-29</xbrli:startDate>
          <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-06-30_custom_SponsorMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aaciu:SponsorMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-06-30</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-06-292021-06-30_custom_WorkingCapitalLoansMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">aaciu:WorkingCapitalLoansMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-06-29</xbrli:startDate>
          <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-06-30_custom_WorkingCapitalLoansMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">aaciu:WorkingCapitalLoansMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-06-30</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_custom_SponsorMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aaciu:SponsorMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-08-16</xbrli:startDate>
          <xbrli:endDate>2021-08-17</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-08-162021-08-18_us-gaap_SubsequentEventMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-08-16</xbrli:startDate>
          <xbrli:endDate>2021-08-18</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-06-16_custom_FounderSharesMember_custom_SponsorMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:FounderSharesMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aaciu:SponsorMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-06-16</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="From2021-07-222021-07-23_us-gaap_SubsequentEventMember_custom_FounderSharesMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:FounderSharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2021-07-22</xbrli:startDate>
          <xbrli:endDate>2021-07-23</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-07-23_us-gaap_SubsequentEventMember_custom_FounderSharesMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:FounderSharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-07-23</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-07-23_us-gaap_SubsequentEventMember_custom_FounderSharesMember_custom_SponsorMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:FounderSharesMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aaciu:SponsorMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-07-23</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:context id="AsOf2021-07-23_us-gaap_SubsequentEventMember_custom_FounderSharesMember_custom_ChiefExecutiveOfficerPresidentAndIndependentDirectorsMember">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001844817</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aaciu:FounderSharesMember</xbrldi:explicitMember>
            <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aaciu:ChiefExecutiveOfficerPresidentAndIndependentDirectorsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
          <xbrli:instant>2021-07-23</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unit>
      <xbrli:unit id="Shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unit>
      <xbrli:unit id="USDPShares">
        <xbrli:divide>
          <xbrli:unitNumerator>
            <xbrli:measure>iso4217:USD</xbrli:measure>
          </xbrli:unitNumerator>
          <xbrli:unitDenominator>
            <xbrli:measure>xbrli:shares</xbrli:measure>
          </xbrli:unitDenominator>
        </xbrli:divide>
      </xbrli:unit>
      <xbrli:unit id="Pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
      </xbrli:unit>
      <xbrli:unit id="Director">
        <xbrli:measure>aaciu:Director</xbrli:measure>
      </xbrli:unit>
      <xbrli:unit id="Investor">
        <xbrli:measure>aaciu:Investor</xbrli:measure>
      </xbrli:unit>
    <ix:relationship fromRefs="Fact000084" toRefs="Footnote000101"></ix:relationship>
    <ix:relationship fromRefs="Fact000111" toRefs="Footnote000116"></ix:relationship>
    <ix:relationship fromRefs="Fact000112" toRefs="Footnote000116"></ix:relationship>
    <ix:relationship fromRefs="xdx2ixbrl0127" toRefs="Footnote000184"></ix:relationship>
    <ix:relationship fromRefs="Fact000134" toRefs="Footnote000184"></ix:relationship>
    <ix:relationship fromRefs="Fact000141" toRefs="Footnote000184"></ix:relationship>
    <ix:relationship fromRefs="Fact000152" toRefs="Footnote000184"></ix:relationship>
    <ix:relationship fromRefs="Fact000161" toRefs="Footnote000184"></ix:relationship>
    <ix:relationship fromRefs="Fact000169" toRefs="Footnote000184"></ix:relationship>
    <ix:relationship fromRefs="Fact000183" toRefs="Footnote000184"></ix:relationship>
    </ix:resources>
   </ix:header>
  </div>
  
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>UNITED STATES</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Washington, D.C. 20549</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>FORM <span id="xdx_901_edei--DocumentType_c20201106__20210630_zSnkbKE4kiD7"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" name="dei:DocumentType">10-Q</ix:nonNumeric></span></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Mark One)</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_90D_edei--DocumentQuarterlyReport_c20201106__20210630_zO16Em71DS9c"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" format="ixt:booleantrue" name="dei:DocumentQuarterlyReport">&#9746;</ix:nonNumeric></span> QUARTERLY REPORT PURSUANT TO SECTION 13
  OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>For the quarterly period ended <span id="xdx_906_edei--DocumentPeriodEndDate_c20201106__20210630_zNa53XusULs3"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">June 30, 2021</ix:nonNumeric></span></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_903_edei--DocumentTransitionReport_c20201106__20210630_zyl3KbbS7hZ5"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span> TRANSITION REPORT PURSUANT TO SECTION 13
  OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Commission File No. <span id="xdx_903_edei--EntityFileNumber_c20201106__20210630_z0OappuL0Sr8"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" name="dei:EntityFileNumber">001-40742</ix:nonNumeric></span></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <tr style="vertical-align: bottom">
      <td style="border-bottom: black 1.5pt solid; width: 100%; text-align: center; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_901_edei--EntityRegistrantName_c20201106__20210630_zcbw6ALNgqma"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" name="dei:EntityRegistrantName">Armada Acquisition Corp. I</ix:nonNumeric></span></b></span></td></tr>
    <tr style="vertical-align: top">
      <td style="text-align: center; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">(Exact name of registrant as specified in its charter)</span></td></tr>
    </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <tr style="vertical-align: bottom">
      <td style="border-bottom: black 1.5pt solid; width: 50%; text-align: center; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_909_edei--EntityIncorporationStateCountryCode_c20201106__20210630_zJPZPr1Of4ld"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
      <td style="width: 1%; text-align: center; font-size: 10pt">&#160;</td>
      <td style="border-bottom: black 1.5pt solid; width: 49%; text-align: center; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90C_edei--EntityTaxIdentificationNumber_c20201106__20210630_zMxSbHLJIWLa"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" name="dei:EntityTaxIdentificationNumber">85-3810850</ix:nonNumeric></span></b></span></td></tr>
    <tr style="vertical-align: top">
      <td>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(State or other jurisdiction of</p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">incorporation or organization)</p></td>
      <td style="text-align: center; font-size: 10pt">&#160;</td>
      <td>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(I.R.S. Employer</p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Identification No.)</p></td></tr>
    </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <tr style="vertical-align: bottom">
      <td style="border-bottom: black 1.5pt solid; width: 100%">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_90F_edei--EntityAddressAddressLine1_c20201106__20210630_zCaDBmuvWDyb"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" name="dei:EntityAddressAddressLine1">2005 Market Street</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressAddressLine2_c20201106__20210630_zDkWcqGfSLkf"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" name="dei:EntityAddressAddressLine2">Suite 3120</ix:nonNumeric></span></b></p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_906_edei--EntityAddressCityOrTown_c20201106__20210630_zR4R3VXkQM6f"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" name="dei:EntityAddressCityOrTown">Philadelphia</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressStateOrProvince_c20201106__20210630_zFhxVfWJjaMj"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" name="dei:EntityAddressStateOrProvince">PA</ix:nonNumeric></span> <span id="xdx_907_edei--EntityAddressPostalZipCode_c20201106__20210630_zkspOmLi6Xt3"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" name="dei:EntityAddressPostalZipCode">1910</ix:nonNumeric></span></b></p></td></tr>
    <tr style="vertical-align: top">
      <td style="text-align: center; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">(Address of Principal Executive Offices, including zip code)</span></td></tr>
    </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <tr style="vertical-align: bottom">
      <td style="border-bottom: black 1.5pt solid; width: 100%; text-align: center; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_905_edei--CityAreaCode_c20201106__20210630_z8rSGmL6179"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" name="dei:CityAreaCode">(215)</ix:nonNumeric></span> <span id="xdx_903_edei--LocalPhoneNumber_c20201106__20210630_z6iPbEHcMDSe"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" name="dei:LocalPhoneNumber">543-6886</ix:nonNumeric></span></b></span></td></tr>
    <tr style="vertical-align: top">
      <td style="text-align: center; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">(Registrant&#8217;s telephone number, including area code)</span></td></tr>
    </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <tr style="vertical-align: bottom">
      <td style="border-bottom: black 1.5pt solid; width: 100%; text-align: center; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>N/A</b></span></td></tr>
    <tr style="vertical-align: top">
      <td style="text-align: center; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">(Former name, former address and former fiscal year, if changed since last report)</span></td></tr>
    </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Securities registered pursuant
  to Section 12(b) of the Act:</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <tr style="vertical-align: bottom">
      <td style="border-bottom: black 1.5pt solid; width: 40%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title of each class</b></span></td>
      <td style="width: 1%; text-align: center">&#160;</td>
      <td style="border-bottom: black 1.5pt solid; width: 20%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading Symbol(s)</b></span></td>
      <td style="width: 1%; text-align: center">&#160;</td>
      <td style="border-bottom: black 1.5pt solid; width: 38%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name of each exchange on which registered</b></span></td></tr>
    <tr style="vertical-align: top; background-color: #CCEEFF">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_edei--Security12bTitle_c20201106__20210630__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneShareOfCommonStockAndOnehalfOfOneRedeemableWarrantMember_z3ZecKuAA3wh"><ix:nonNumeric contextRef="From2020-11-062021-06-30_custom_UnitsEachConsistingOfOneShareOfCommonStockAndOnehalfOfOneRedeemableWarrantMember" name="dei:Security12bTitle">Units, each consisting of one share of Common Stock and one-half of one Redeemable Warrant</ix:nonNumeric></span></span></td>
      <td style="text-align: center">&#160;</td>
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_edei--TradingSymbol_c20201106__20210630__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneShareOfCommonStockAndOnehalfOfOneRedeemableWarrantMember_ziYDxvXykFmk"><ix:nonNumeric contextRef="From2020-11-062021-06-30_custom_UnitsEachConsistingOfOneShareOfCommonStockAndOnehalfOfOneRedeemableWarrantMember" name="dei:TradingSymbol">AACIU</ix:nonNumeric></span></span></td>
      <td style="text-align: center">&#160;</td>
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90F_edei--SecurityExchangeName_c20201106__20210630__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneShareOfCommonStockAndOnehalfOfOneRedeemableWarrantMember_zLwG2g2C0MJl"><ix:nonNumeric contextRef="From2020-11-062021-06-30_custom_UnitsEachConsistingOfOneShareOfCommonStockAndOnehalfOfOneRedeemableWarrantMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
    <tr style="vertical-align: top; background-color: white">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_edei--Security12bTitle_c20201106__20210630__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_ze5tES8ldi2a"><ix:nonNumeric contextRef="From2020-11-062021-06-30_custom_CommonStockParValue0.0001PerShareMember" name="dei:Security12bTitle">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
      <td style="text-align: center">&#160;</td>
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_edei--TradingSymbol_c20201106__20210630__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zjt53KXUJZZ9"><ix:nonNumeric contextRef="From2020-11-062021-06-30_custom_CommonStockParValue0.0001PerShareMember" name="dei:TradingSymbol">AACI</ix:nonNumeric></span></span></td>
      <td style="text-align: center">&#160;</td>
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_edei--SecurityExchangeName_c20201106__20210630__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zciivoompHLj"><ix:nonNumeric contextRef="From2020-11-062021-06-30_custom_CommonStockParValue0.0001PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
    <tr style="vertical-align: top; background-color: #CCEEFF">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_edei--Security12bTitle_c20201106__20210630__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableForOneShareOfCommonStockFor11.50PerShareMember_zgLhq2J7q1R"><ix:nonNumeric contextRef="From2020-11-062021-06-30_custom_WarrantsEachExercisableForOneShareOfCommonStockFor11.50PerShareMember" name="dei:Security12bTitle">Warrants, each exercisable for one share of Common Stock for $11.50 per share</ix:nonNumeric></span></span></td>
      <td style="text-align: center">&#160;</td>
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90F_edei--TradingSymbol_c20201106__20210630__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableForOneShareOfCommonStockFor11.50PerShareMember_z4b3TigajHB5"><ix:nonNumeric contextRef="From2020-11-062021-06-30_custom_WarrantsEachExercisableForOneShareOfCommonStockFor11.50PerShareMember" name="dei:TradingSymbol">AACIW</ix:nonNumeric></span></span></td>
      <td style="text-align: center">&#160;</td>
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_edei--SecurityExchangeName_c20201106__20210630__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableForOneShareOfCommonStockFor11.50PerShareMember_zWVpd33YJMq1"><ix:nonNumeric contextRef="From2020-11-062021-06-30_custom_WarrantsEachExercisableForOneShareOfCommonStockFor11.50PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
    </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Indicate by check mark whether
  the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
  preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
  filing requirements for the past 90 days. Yes &#9744;&#160;&#160;&#160;<span id="xdx_905_edei--EntityCurrentReportingStatus_c20201106__20210630_zQLlUlTWUdF8"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" name="dei:EntityCurrentReportingStatus">No</ix:nonNumeric></span> &#9746;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>
  
  <!-- Field: Page; Sequence: 1 -->
      <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"></p><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div>
      <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#TOC">Table of Contents</a></p></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Indicate by check mark whether
  the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T
  (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit
  such files). <span id="xdx_90A_edei--EntityInteractiveDataCurrent_c20201106__20210630_z0aQN7qYQfqg"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> &#9746;&#160;&#160;&#160;No &#9744;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Indicate by check mark whether
  the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging
  growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting
  company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <tr style="vertical-align: top">
      <td style="white-space: nowrap; width: 48px">&#160;</td>
      <td style="white-space: nowrap; width: 45%"><span style="font: 10pt Times New Roman, Times, Serif">&#9744;&#160;Large accelerated filer</span></td>
      <td style="white-space: nowrap"><span style="font: 10pt Times New Roman, Times, Serif">&#9744;&#160;Accelerated filer</span></td></tr>
    <tr style="vertical-align: top">
      <td style="white-space: nowrap">&#160;</td>
      <td style="white-space: nowrap"><span style="font: 10pt Times New Roman, Times, Serif">&#9746;&#160;<span id="xdx_90E_edei--EntityFilerCategory_c20201106__20210630_z0x3a3NSLmBh"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span></span></td>
      <td style="white-space: nowrap"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_edei--EntitySmallBusiness_c20201106__20210630_zqTm0HbZGqPc"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span>&#160;Smaller reporting company</span></td></tr>
    <tr style="vertical-align: top">
      <td style="white-space: nowrap">&#160;</td>
      <td style="white-space: nowrap">&#160;</td>
      <td style="white-space: nowrap"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20201106__20210630_zVg9zd4vQC0a"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span>&#160;Emerging growth company</span></td></tr>
    </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If an emerging growth company,
  indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
  accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_907_edei--EntityExTransitionPeriod_c20201106__20210630_zZdyQRKeA8Q2"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Indicate by check mark whether
  the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act):&#160;<span id="xdx_907_edei--EntityShellCompany_c20201106__20210630_zWr4GUffYYq4"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" format="ixt:booleantrue" name="dei:EntityShellCompany">Yes</ix:nonNumeric></span>&#160;&#9746;&#160;&#160;&#160;No &#9744;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of September 27, 2021, there
  were <span id="xdx_90C_edei--EntityCommonStockSharesOutstanding_iI_c20210927_zWvudq0XyDDj"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2021-09-27" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">21,834,500</ix:nonFraction></span> shares of common stock issued and outstanding.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>
  
  
  <!-- Field: Page; Sequence: 2 -->
      <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"></p><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div>
      <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#TOC">Table of Contents</a></p></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>ARMADA ACQUISITION CORP. I</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Quarterly Report on Form 10-Q</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b><span id="TOC"></span>Table
  of Contents</b></span>&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <tr style="background-color: #CCEEFF">
      <td colspan="3" style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_001">PART&#160;I. FINANCIAL INFORMATION</a></span></td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
    <tr style="background-color: white">
      <td style="vertical-align: top; width: 8%; text-align: justify">&#160;</td>
      <td style="vertical-align: top; width: 1%; text-align: justify">&#160;</td>
      <td style="vertical-align: top; width: 82%; padding-left: 9pt; text-align: justify; text-indent: -9pt">&#160;</td>
      <td style="vertical-align: bottom; width: 1%">&#160;</td>
      <td style="vertical-align: bottom; width: 8%; text-align: center">&#160;</td></tr>
    <tr style="background-color: #CCEEFF">
      <td style="vertical-align: top; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_002">Item&#160;1.</a></span></td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_002">Financial Statements</a></span></td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_002">1</a></span></td></tr>
    <tr style="background-color: white">
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt">&#160;</td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
    <tr style="background-color: #CCEEFF">
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_003">Unaudited Condensed Balance Sheet as of June 30, 2021</a></span></td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_003">1</a></span></td></tr>
    <tr style="background-color: white">
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt">&#160;</td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
    <tr style="background-color: #CCEEFF">
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_004">Unaudited Condensed Statements of Operations for the Three Months ended June 30, 2021 and for the period from November 5, 2020 (Inception) through June 30, 2021</a></span></td>
      <td style="vertical-align: bottom"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><a href="#a_004">2</a></span></td></tr>
    <tr style="background-color: white">
      <td style="vertical-align: top; text-align: justify"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: top; text-align: justify"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: bottom"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: bottom; text-align: center"><span style="color: #000000">&#160;</span></td></tr>
    <tr style="background-color: #CCEEFF">
      <td style="vertical-align: top; text-align: justify"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: top; text-align: justify"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><a href="#a_005">Unaudited Condensed Statement of Changes in Stockholders&#8217; Equity for the period from November 5, 2020 (Inception) through June 30, 2021</a></span></td>
      <td style="vertical-align: bottom"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><a href="#a_005">3</a></span></td></tr>
    <tr style="background-color: white">
      <td style="vertical-align: top; text-align: justify"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: top; text-align: justify"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: bottom"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: bottom; text-align: center"><span style="color: #000000">&#160;</span></td></tr>
    <tr style="background-color: #CCEEFF">
      <td style="vertical-align: top; text-align: justify"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: top; text-align: justify"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><a href="#a_006">Unaudited Condensed Statement of Cash Flows for the period from November 5, 2020 (Inception) through June 30, 2021</a></span></td>
      <td style="vertical-align: bottom"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><a href="#a_006">4</a></span></td></tr>
    <tr style="background-color: white">
      <td style="vertical-align: top; text-align: justify"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: top; text-align: justify"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: bottom"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: bottom; text-align: center"><span style="color: #000000">&#160;</span></td></tr>
    <tr style="background-color: #CCEEFF">
      <td style="vertical-align: top; text-align: justify"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: top; text-align: justify"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><a href="#a_007">Notes to Unaudited Condensed Financial Statements</a></span></td>
      <td style="vertical-align: bottom"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><a href="#a_007">5</a></span></td></tr>
    <tr style="background-color: white">
      <td style="vertical-align: top; text-align: justify"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: top; text-align: justify"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: bottom"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: bottom; text-align: center"><span style="color: #000000">&#160;</span></td></tr>
    <tr style="background-color: #CCEEFF">
      <td style="vertical-align: top; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><a href="#a_008">Item&#160;2.</a></span></td>
      <td style="vertical-align: top; text-align: justify"><span style="color: #000000">&#160;</span></td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><a href="#a_008">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_008">16</a></span></td></tr>
    <tr style="background-color: white">
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt">&#160;</td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
    <tr style="background-color: #CCEEFF">
      <td style="vertical-align: top; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_009">Item&#160;3.</a></span></td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_009">Quantitative and Qualitative Disclosures About Market Risk</a></span></td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_009">18</a></span></td></tr>
    <tr style="background-color: white">
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt">&#160;</td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
    <tr style="background-color: #CCEEFF">
      <td style="vertical-align: top; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_010">Item&#160;4.</a></span></td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_010">Controls and Procedures</a></span></td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_010">18</a></span></td></tr>
    <tr style="background-color: white">
      <td colspan="3" style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt">&#160;</td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
    <tr style="background-color: #CCEEFF">
      <td colspan="3" style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_011">PART&#160;II. OTHER INFORMATION</a></span></td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
    <tr style="background-color: white">
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt">&#160;</td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
    <tr style="background-color: #CCEEFF">
      <td style="vertical-align: top; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_012">Item&#160;1.</a></span></td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_012">Legal Proceedings</a></span></td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_012">20</a></span></td></tr>
    <tr style="background-color: white">
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt">&#160;</td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
    <tr style="background-color: #CCEEFF">
      <td style="vertical-align: top; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_013">Item&#160;1A.</a></span></td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_013">Risk Factors</a></span></td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_013">20</a></span></td></tr>
    <tr style="background-color: white">
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt">&#160;</td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
    <tr style="background-color: #CCEEFF">
      <td style="vertical-align: top; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_014">Item&#160;2.</a></span></td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_014">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_014">20</a></span></td></tr>
    <tr style="background-color: white">
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt">&#160;</td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
    <tr style="background-color: #CCEEFF">
      <td style="vertical-align: top; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_015">Item&#160;3.</a></span></td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_015">Defaults Upon Senior Securities</a></span></td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_015">20</a></span></td></tr>
    <tr style="background-color: white">
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt">&#160;</td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
    <tr style="background-color: #CCEEFF">
      <td style="vertical-align: top; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_016">Item&#160;4.</a></span></td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_016">Mine Safety Disclosures</a></span></td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_016">20</a></span></td></tr>
    <tr style="background-color: white">
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt">&#160;</td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
    <tr style="background-color: #CCEEFF">
      <td style="vertical-align: top; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_017">Item&#160;5.</a></span></td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_017">Other Information</a></span></td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_017">20</a></span></td></tr>
    <tr style="background-color: white">
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt">&#160;</td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
    <tr style="background-color: #CCEEFF">
      <td style="vertical-align: top; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_018">Item&#160;6.</a></span></td>
      <td style="vertical-align: top; text-align: justify">&#160;</td>
      <td style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_018">Exhibits</a></span></td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_018">21</a></span></td></tr>
    <tr style="background-color: white">
      <td colspan="3" style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt">&#160;</td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
    <tr style="background-color: #CCEEFF">
      <td colspan="3" style="vertical-align: top; padding-left: 9pt; text-align: justify; text-indent: -9pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_019">SIGNATURES</a></span></td>
      <td style="vertical-align: bottom">&#160;</td>
      <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_019">22</a></span></td></tr>
    </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"></p>
  
  <!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
      <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"></p><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p><p style="margin: 0pt"></p></div>
      <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; font-size: 10pt"><a href="#TOC">Table of Contents</a></p></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="background-color: white"><b><span id="a_001"></span>PART&#160;I
  - FINANCIAL INFORMATION</b></span></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="a_002"></span><span style="background-color: white"><b>Item&#160;1.
  Financial Statements.</b></span></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="color: #252525"><b>Armada
  Acquisition Corp. I<br />
  </b></span><b><span id="a_003"></span>UNAUDITED CONDENSED BALANCE SHEET</b>&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>JUNE 30, 2021</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #252525">&#160;</p>
  
  <table cellpadding="0" cellspacing="0" id="xdx_30F_111_zvDekOYmqQhg" summary="xdx: Statement - UNAUDITED CONDENSED BALANCE SHEET" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
    <tr id="xdx_40F_eus-gaap--AssetsAbstract_iB_zz5ANG70duTe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="color: black; font-weight: bold">Assets</td><td>&#160;</td>
      <td colspan="3" id="xdx_490_20210630_z4mrqxnXX3t7">&#160;</td></tr>
    <tr id="xdx_40C_eus-gaap--Cash_i01I_maAzS6I_zgL5BVWg7Hcf" style="vertical-align: bottom; background-color: White">
      <td style="width: 70%; color: black; padding-left: 5.4pt">Cash</td><td style="width: 10%; color: black">&#160;</td>
      <td style="width: 1%; color: black; text-align: left">$</td><td style="width: 18%; color: black; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,746</ix:nonFraction></td><td style="width: 1%; color: black; text-align: left">&#160;</td></tr>
    <tr id="xdx_408_eus-gaap--DueFromAffiliates_i01I_maAzS6I_zpYtw0O94m9j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="color: black; text-align: left; padding-left: 5.4pt">Due from Sponsor</td><td style="color: black">&#160;</td>
      <td style="color: black; text-align: left">&#160;</td><td style="color: black; text-align: right"><ix:nonFraction name="us-gaap:DueFromAffiliates" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,070</ix:nonFraction></td><td style="color: black; text-align: left">&#160;</td></tr>
    <tr id="xdx_40A_eus-gaap--PrepaidExpenseCurrentAndNoncurrent_i01I_maAzS6I_zok2xXa0y2u5" style="vertical-align: bottom; background-color: White">
      <td style="color: black; text-align: left; padding-left: 5.4pt">Prepaid expenses</td><td style="color: black">&#160;</td>
      <td style="color: black; text-align: left">&#160;</td><td style="color: black; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrentAndNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,171</ix:nonFraction></td><td style="color: black; text-align: left">&#160;</td></tr>
    <tr id="xdx_40F_eus-gaap--DeferredOfferingCosts_i01I_maAzS6I_z57coXtHTYei" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="color: black; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Deferred offering costs</td><td style="color: black; padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">168,285</ix:nonFraction></td><td style="padding-bottom: 1pt; color: black; text-align: left">&#160;</td></tr>
    <tr id="xdx_408_eus-gaap--Assets_i01TI_mtAzS6I_zMkYDmxWjxv" style="vertical-align: bottom; background-color: White">
      <td style="color: black; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Total Assets</td><td style="color: black; padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">219,272</ix:nonFraction></td><td style="padding-bottom: 2.5pt; color: black; text-align: left">&#160;</td></tr>
    <tr id="xdx_402_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zCv9mpt2IJni" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="color: black; font-weight: bold; text-align: left; padding-left: 5.4pt">Liabilities and Stockholders&#8217; Equity</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_407_eus-gaap--LiabilitiesCurrentAbstract_i01B_z1ZgeIGPeXFk" style="vertical-align: bottom; background-color: White">
      <td style="color: black; text-align: left; padding-left: 5.4pt">Current liabilities:</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_40F_eus-gaap--AccruedLiabilitiesCurrent_i02I_maLCz9Oz_zG4ZwpOWOhub" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="color: black; text-align: left; padding-left: 5.4pt">Accrued offering costs and expenses</td><td style="color: black">&#160;</td>
      <td style="color: black; text-align: left">$</td><td style="color: black; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,258</ix:nonFraction></td><td style="color: black; text-align: left">&#160;</td></tr>
    <tr id="xdx_408_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_i02I_maLCz9Oz_zWSdMBBFXxIi" style="vertical-align: bottom; background-color: White">
      <td style="color: black; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Advances from related parties</td><td style="color: black; padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><ix:nonFraction name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,352</ix:nonFraction></td><td style="padding-bottom: 1pt; color: black; text-align: left">&#160;</td></tr>
    <tr id="xdx_408_eus-gaap--LiabilitiesCurrent_i02TI_mtLCz9Oz_maLASEzv2H_z6xSH38sCikh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="color: black; font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total current liabilities</td><td style="color: black; padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">194,610</ix:nonFraction></td><td style="padding-bottom: 1pt; color: black; text-align: left">&#160;</td></tr>
    <tr id="xdx_40B_eus-gaap--CommitmentsAndContingencies_i01I_zanwiUioyTZg" style="vertical-align: bottom; background-color: White">
      <td style="color: black; font-weight: bold; text-align: left; padding-left: 5.4pt">Commitments and Contingencies (Note 6)</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right; display: none"><span style="-sec-ix-hidden: xdx2ixbrl0070">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_403_eus-gaap--StockholdersEquityAbstract_i01B_zct21erJKqi6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="color: black; font-weight: bold; text-align: left; padding-left: 5.4pt">Stockholders&#8217; Equity:</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_401_eus-gaap--PreferredStockValue_i02I_maSEzGw7_ztW3RJ6BfJ0h" style="vertical-align: bottom; background-color: White">
      <td style="text-align: left; padding-left: 5.4pt">Preferred stock, $<span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20210630_zANe2usgVQyl" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> par value; <span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_c20210630_zQHKc2cC302c" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> shares authorized; <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_dn_c20210630_ziGY6BX2drtg" title="Preferred stock, shares issued"><span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20210630_zkOlxjnMlpKk" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-06-30" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-06-30" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></span></span> issued and outstanding</td><td style="color: black">&#160;</td>
      <td style="color: black; text-align: left">&#160;</td><td style="color: black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0074">&#8212;</span>&#160;&#160;</td><td style="color: black; text-align: left">&#160;</td></tr>
    <tr id="xdx_405_eus-gaap--CommonStockValue_i02I_maSEzGw7_zqTHwmuOCmtf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="color: black; padding-left: 5.4pt"><span style="font: 10pt Times New Roman, Times, Serif; color: black">Common stock, $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210630_zh3lAyEsDmxk" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> par value; <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_c20210630_z6Z3SlOOYCy2" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></span> shares authorized; <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_dn_c20210630_zgfmRKSNt8vf" title="Common stock, shares issued"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_dn_c20210630_zqsgN0xLL7ij" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,175,000</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding<sup id="xdx_F49_zx4eNyw2ylNl">(1)</sup></span></td><td style="color: black">&#160;</td>
      <td style="color: black; text-align: left">&#160;</td><td style="color: black; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-06-30" id="Fact000084" format="ixt:numdotdecimal" decimals="0" unitRef="USD">517</ix:nonFraction></td><td style="color: black; text-align: left">&#160;</td></tr>
    <tr id="xdx_404_eus-gaap--AdditionalPaidInCapitalCommonStock_i02I_maSEzGw7_zRZbKQuGniZj" style="vertical-align: bottom; background-color: White">
      <td style="color: black; text-align: left; padding-left: 5.4pt">Additional paid-in capital</td><td style="color: black">&#160;</td>
      <td style="color: black; text-align: left">&#160;</td><td style="color: black; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,553</ix:nonFraction></td><td style="color: black; text-align: left">&#160;</td></tr>
    <tr id="xdx_409_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzGw7_ztBxKd3RUBte" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="color: black; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Accumulated deficit</td><td style="color: black; padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: black; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,408</ix:nonFraction></td><td style="padding-bottom: 1pt; color: black; text-align: left">)</td></tr>
    <tr id="xdx_40F_eus-gaap--StockholdersEquity_i02TI_mtSEzGw7_maLASEzv2H_zsopMV2ah7Kd" style="vertical-align: bottom; background-color: White">
      <td style="color: black; font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total stockholders&#8217; equity</td><td style="color: black; padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: black; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,662</ix:nonFraction></td><td style="padding-bottom: 1pt; color: black; text-align: left">&#160;</td></tr>
    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
    <tr id="xdx_405_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzv2H_zGZ4GXYLq7T1" style="vertical-align: bottom; background-color: White">
      <td style="color: black; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Total Liabilities and Stockholders&#8217; Equity</td><td style="color: black; padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">219,272</ix:nonFraction></td><td style="padding-bottom: 2.5pt; color: black; text-align: left">&#160;</td></tr>
    </table>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>
  
  <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt; background-color: white"><tr style="vertical-align: top">
  <td style="width: 0.25in"></td><td id="xdx_F0A_zWmdyYefsyvl" style="width: 0.25in">(1)</td><td id="xdx_F1F_z6mig5SNjJck"><ix:footnote id="Footnote000101" xml:lang="en-US">Includes up to <span id="xdx_90C_eus-gaap--CommonStockOtherSharesOutstanding_iI_dn_c20210630_zBNX9ssgfgI5" title="Common stock, shares subject to forfeiture"><ix:nonFraction name="us-gaap:CommonStockOtherSharesOutstanding" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">675,000</ix:nonFraction></span> shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters
  (see Note 5).</ix:footnote></td></tr></table>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; background-color: white">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; background-color: white">The accompanying notes
  are an integral part of these unaudited condensed financial statements.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; background-color: white">&#160;</p>
  
  
  <!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; color: #252525"><b>&#160;</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white; color: #252525"><b>Armada
  Acquisition Corp. I</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b><span id="a_004"></span>UNAUDITED CONDENSED STATEMENTS
  OF OPERATIONS</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #252525">&#160;</p>
  
  <table cellpadding="0" cellspacing="0" id="xdx_30D_113_zUomFmPV0vb4" summary="xdx: Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
    <tr style="vertical-align: bottom">
      <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
      <td colspan="3" id="xdx_496_20210401__20210630_zeIxMRW8Hjkh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months Ended June 30, 2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
      <td colspan="3" id="xdx_493_20201106__20210630_ztGEIIwKYXy1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the period from November 5, 2020 (Inception) through June 30, 2021</td></tr>
    <tr id="xdx_408_eus-gaap--OperatingExpenses_msNILzx8u_zW7BWXA4BEmh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="width: 56%; color: black; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p>
                                                                                  <p style="margin-top: 0; margin-bottom: 0">Formation cost</p></td><td style="width: 8%; color: black; padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; width: 1%; color: black; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 12%; color: black; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,969</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; color: black; text-align: left">&#160;</td><td style="width: 8%; color: black; padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; width: 1%; color: black; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 12%; color: black; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2020-11-06to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,408</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; color: black; text-align: left">&#160;</td></tr>
    <tr id="xdx_400_eus-gaap--NetIncomeLoss_iT_mtNILzx8u_zs0yQSHy1Xb1" style="vertical-align: bottom; background-color: White">
      <td style="color: black; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p>
                                                                                  <p style="margin-top: 0; margin-bottom: 0">Net loss</p></td><td style="color: black; padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,969</ix:nonFraction></td><td style="padding-bottom: 2.5pt; color: black; text-align: left">)</td><td style="color: black; padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-06to2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,408</ix:nonFraction></td><td style="padding-bottom: 2.5pt; color: black; text-align: left">)</td></tr>
    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_405_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_zd3qqWp20rcc" style="vertical-align: bottom; background-color: White">
      <td style="color: black; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font: 10pt Times New Roman, Times, Serif; color: black">Basic and diluted weighted average shares outstanding<sup id="xdx_F47_zDM0ZZ44HxY1">(1)</sup></span></td><td style="color: black; padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-04-012021-06-30" id="Fact000111" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,500,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; color: black; text-align: left">&#160;</td><td style="color: black; padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-11-06to2021-06-30" id="Fact000112" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,500,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; color: black; text-align: left">&#160;</td></tr>
    <tr id="xdx_409_eus-gaap--EarningsPerShareBasicAndDiluted_zbFRTucFww82" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="color: black; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p>
                                                                                  <p style="margin-top: 0; margin-bottom: 0">Basic and diluted net loss per share</p></td><td style="color: black; padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; color: black; text-align: left">)</td><td style="color: black; padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: black; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-11-06to2021-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; color: black; text-align: left">)</td></tr>
    </table>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #252525">&#160;</p>
  
  <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt; background-color: white"><tr style="vertical-align: top">
  <td style="width: 0.25in"></td><td id="xdx_F0D_zeLpps0XY5ad" style="width: 0.25in">(1)</td><td id="xdx_F18_zerYigsqF24g"><ix:footnote id="Footnote000116" xml:lang="en-US">Excludes <span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20210401__20210630_z7rDLJcuaaY7" title="Shares subject to forfeiture"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_c20201106__20210630_ztOPKWX9b26b" title="Shares subject to forfeiture"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" contextRef="From2020-11-06to2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">675,000</ix:nonFraction></ix:nonFraction></span></span> shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters
  (see Note 5).</ix:footnote></td></tr></table>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">The accompanying notes are
  an integral part of these unaudited condensed financial statements.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>
  
  
  <!-- Field: Page; Sequence: 5 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #252525"><b>Armada Acquisition Corp. I</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="a_005"></span>UNAUDITED CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS&#8217;
  EQUITY<br />
  FOR THE PERIOD FROM NOVEMBER 5, 2020 (INCEPTION) THROUGH JUNE 30, 2021</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>
  
  <table cellpadding="0" cellspacing="0" id="xdx_30B_114_z7D4dbLADNri" summary="xdx: Statement - UNAUDITED CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS&apos; EQUITY" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; display: none">
      <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
      <td colspan="3" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
      <td colspan="3" id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zkq1D1ZmdKdb" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
      <td colspan="3" id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zksRzNIwfSU3" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
      <td colspan="3" id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_z4thyb25rXv6" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
      <td colspan="3" id="xdx_4B1_z2G1ZrUTfoY9" style="font-weight: bold; text-align: center">&#160;</td></tr>
    <tr style="vertical-align: bottom">
      <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
      <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
      <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Additional</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
      <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
      <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Stockholders'</td></tr>
  
    <tr style="vertical-align: bottom">
      <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
      <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;Shares<sup>(1)</sup></b></span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
      <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
      <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Paid-in Capital</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
      <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
      <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Equity</td></tr>
    <tr id="xdx_43E_c20201106__20210331_eus-gaap--StockholdersEquity_iS_zcUDspCdiJgj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="width: 35%; font-weight: bold; padding-left: 5.4pt">Balance as of November 5, 2020 (inception)</td><td style="width: 2%">&#160;</td>
      <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--CommonStockSharesIssued_iS_c20201106__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fMQ_____zsyCuJryw7ce" title="Beginning balance, shares" style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0127">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
      <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0122">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
      <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0123">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
      <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0124">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
      <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0125">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
    <tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zHsocX8Uet31" style="vertical-align: bottom; background-color: White">
      <td style="text-align: left; padding-left: 5.4pt">Common Stock issued to Sponsor</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201106__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fMQ_____ztXfRJ0ZLn3i" title="Common Stock issued to Sponsor, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-11-062021-03-31_us-gaap_CommonStockMember" id="Fact000134" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,312,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-11-062021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">431</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-11-062021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,569</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0131">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-11-062021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_40A_eus-gaap--StockIssuedDuringPeriodValueOther_zF5NWG63OHQg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="padding-left: 5.4pt">Issuance of Representative shares</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesOther_c20201106__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fMQ_____zbKQ99P7Th5h" title="Issuance of Representative shares, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2020-11-062021-03-31_us-gaap_CommonStockMember" id="Fact000141" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2020-11-062021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2020-11-062021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0138">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0139">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_40D_eus-gaap--NetIncomeLoss_zO1yGkZBfZp8" style="vertical-align: bottom; background-color: White">
      <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0143">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0144">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-062021-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,439</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-062021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,439</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
    <tr id="xdx_438_c20210401__20210630_eus-gaap--StockholdersEquity_iS_zEnAFboAmdk5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 5.4pt">Balance as of March 31, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--CommonStockSharesIssued_iS_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fMQ_____zftcVnxHl1Y1" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" id="Fact000152" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,562,500</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">456</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,544</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,439</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,561</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
    <tr id="xdx_400_eus-gaap--StockRepurchasedAndRetiredDuringPeriodValue_iNP3us-gaap--CommonStockSharesIssued_di_zKmDYxapDX2b" style="vertical-align: bottom; background-color: White">
      <td style="text-align: left; padding-left: 5.4pt"><span id="xdx_90B_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_c20210401__20210630_zdV6dJmi9Mu" title="Representative shares returned to the Company, shares"><ix:nonFraction name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">87,500</ix:nonFraction></span> of Representative shares returned to the Company</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_iNP3us-gaap--StockRepurchasedAndRetiredDuringPeriodValue_di_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fMQ_____z0Z4MZV8ZZoj" title="87,500 of Representative shares returned to the Company, shares" style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" id="Fact000161" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">87,500</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0156">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0157">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_z5PCVXsY8Igj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="text-align: left; padding-left: 5.4pt">Additional <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210401__20210630_zKKowgMSeWh9" title="Common Stock issued to Sponsor, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">700,000</ix:nonFraction></span> shares of Common Stock issued to Sponsor</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fMQ_____zUFitCgYcjdf" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" id="Fact000169" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">700,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0165">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210401__20210630_zkXkDyeWSZLg" title="Common Stock issued to Sponsor" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,070</ix:nonFraction></ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_403_eus-gaap--NetIncomeLoss_ziEMIk40wyQ1" style="vertical-align: bottom; background-color: White">
      <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0173">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0174">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,969</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,969</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
    <tr id="xdx_434_c20210401__20210630_eus-gaap--StockholdersEquity_iE_zPhaB3gQBi5a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 5.4pt">Balance as of June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--CommonStockSharesIssued_iE_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fMQ_____zZ0WQPEu7f4i" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" id="Fact000183" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,175,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">517</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,553</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,408</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,662</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
    </table>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>
  
  <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt; background-color: white"><tr style="vertical-align: top">
  <td style="width: 0.25in"></td><td id="xdx_F02_z9TmwbSMzTqj" style="width: 0.25in">(1)</td><td id="xdx_F12_zi73iTt5Ky39"><ix:footnote id="Footnote000184" xml:lang="en-US">Includes up to <span id="xdx_901_eus-gaap--CommonStockOtherSharesOutstanding_iI_dn_c20210630_zpughDH8bByd" title="Common stock, shares subject to forfeiture"><ix:nonFraction name="us-gaap:CommonStockOtherSharesOutstanding" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">675,000</ix:nonFraction></span> shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters
  (see Note 5).</ix:footnote></td></tr></table>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">The accompanying notes are
  an integral part of these unaudited condensed financial statements.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center; background-color: white; color: #252525">&#160;</p>
  
  
  <!-- Field: Page; Sequence: 6 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: center; background-color: white; color: #252525"><b>Armada
  Acquisition Corp. I</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center; background-color: white; color: #252525"><span id="a_006"></span><b>UNAUDITED CONDENSED STATEMENT OF CASH FLOWS<br />
  FOR THE PERIOD FROM NOVEMBER 5, 2020 (INCEPTION) THROUGH JUNE 30, 2021</b></p>
  
  <table cellpadding="0" cellspacing="0" id="xdx_30E_112_z3xFkWXLQ1E" summary="xdx: Statement - UNAUDITED CONDENSED STATEMENT OF CASH FLOWS" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
    <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zKjnfDN6Igg6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="font-weight: bold">Cash Flows from Operating Activities:</td><td>&#160;</td>
      <td colspan="3" id="xdx_494_20201106__20210630_zGVdpwarCD6a">&#160;</td></tr>
    <tr id="xdx_401_eus-gaap--NetIncomeLoss_i01_maNCPBUzJqu_zR6IhvDxvtXi" style="vertical-align: bottom; background-color: White">
      <td style="width: 70%; text-align: left; padding-left: 10pt">Net loss</td><td style="width: 10%">&#160;</td>
      <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-06to2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,408</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
    <tr id="xdx_404_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_z5YkP0aKEla6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="text-align: left; padding-left: 10pt">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_40B_eus-gaap--AdjustmentForAmortization_i02_maNCPBUzJqu_zO41OxkpVGEg" style="vertical-align: bottom; background-color: White">
      <td style="text-align: left; text-indent: 20pt; padding-left: 0pt">Amortization of prepaid expenses</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentForAmortization" contextRef="From2020-11-06to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,629</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i01B_zJv0OoIXowG3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="text-align: left; padding-left: 20pt">Changes in current assets and liabilities:</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_408_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i02_maNCPBUzJqu_zMZ2zPCy8Pr6" style="vertical-align: bottom; background-color: White">
      <td style="text-align: left; padding-left: 30pt">Accrued expenses</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2020-11-06to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,400</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_405_eus-gaap--IncreaseDecreaseInPrepaidExpense_i02N_di_msNCPBUzJqu_zSC54iU212O8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="text-align: left; padding-bottom: 1pt; text-indent: 30pt; padding-left: 0pt">Prepaid assets</td><td style="padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2020-11-06to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,800</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
    <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtNCPBUzJqu_maCCERCzIMa_zTuY1QCJ3KKa" style="vertical-align: bottom; background-color: White">
      <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: 30.1pt; padding-left: 10pt">Net cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-11-06to2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,179</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zcWPhvAKSSt" style="vertical-align: bottom; background-color: White">
      <td style="font-weight: bold; text-align: left; padding-left: 0pt">Cash Flows from Financing Activities:</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_40A_eus-gaap--ProceedsFromRelatedPartyDebt_i01_maNCPBUzDqH_zlxaguUoNGC" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="text-align: left; text-indent: 20pt; padding-left: 0pt">Advances from related parties</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2020-11-06to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,352</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_407_eus-gaap--PaymentsOfStockIssuanceCosts_i01N_di_msNCPBUzDqH_zJOIZxKn6p2j" style="vertical-align: bottom; background-color: White">
      <td style="text-align: left; padding-bottom: 1pt; text-indent: 20pt; padding-left: 0pt">Payment of deferred offering costs</td><td style="padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2020-11-06to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">111,427</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
    <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzDqH_maCCERCzIMa_zHZKJfKO8yi2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 30pt">Net cash provided by financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-11-06to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,925</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
    <tr style="vertical-align: bottom; background-color: White">
      <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzIMa_z0ZWPkfwVY6a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="font-weight: bold; text-align: left; padding-left: 0pt">Net change in cash</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2020-11-06to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,746</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_401_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iS_zVzolPYM5UX5" style="vertical-align: bottom; background-color: White">
      <td style="font-weight: bold; padding-bottom: 1pt; padding-left: 0pt">Cash, November 5, 2020 (inception)</td><td style="padding-bottom: 1pt">&#160;</td>
      <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0213">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
    <tr id="xdx_402_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iE_zfObDTMZS2uh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Cash, end of the period</td><td style="padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,746</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
    <tr style="vertical-align: bottom; background-color: White">
      <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_40E_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zNznBu6VHC3h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="font-weight: bold; text-align: left; padding-left: 0pt">Supplemental disclosure of noncash investing and financing activities</td><td>&#160;</td>
      <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
    <tr id="xdx_407_ecustom--DueFromSponsorFromSaleOfCommonStockToInitialStockholders_i01_zYtAC2m8GHk2" style="vertical-align: bottom; background-color: White">
      <td style="text-align: left; padding-bottom: 2.5pt; text-indent: 20pt; padding-left: 0pt">Due from Sponsor from sale of common stock to initial stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="aaciu:DueFromSponsorFromSaleOfCommonStockToInitialStockholders" contextRef="From2020-11-06to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,070</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
    <tr id="xdx_40E_ecustom--DeferredOfferingCostsPaidBySponsorInExchangeForCommonStock_i01_z9n29K0ntJC5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="text-align: left; padding-bottom: 2.5pt; text-indent: 20pt; padding-left: 0pt">Deferred offering costs paid by Sponsor in exchange for common stock</td><td style="padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="aaciu:DeferredOfferingCostsPaidBySponsorInExchangeForCommonStock" contextRef="From2020-11-06to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
    <tr id="xdx_400_ecustom--AccruedDeferredOfferingCosts_i01_zuDfkyfohp1g" style="vertical-align: bottom; background-color: White">
      <td style="text-align: left; padding-bottom: 2.5pt; text-indent: 20pt; padding-left: 0pt">Accrued deferred offering costs</td><td style="padding-bottom: 2.5pt">&#160;</td>
      <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="aaciu:AccruedDeferredOfferingCosts" contextRef="From2020-11-06to2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,858</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
    </table>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">The accompanying notes are
  an integral part of these unaudited condensed financial statements.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #252525">&#160;</p>
  
  
  <!-- Field: Page; Sequence: 7 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #252525"><b><span id="a_007"></span>Armada Acquisition Corp. I<br />
  NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENT</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #252525">&#160;</p>
  
  <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_80F_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zIZ7euDIc6B5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b>Note 1 &#8212; <span id="xdx_827_zNrqW3e5hiP8">Organization, Business
  Operation and Going Concern</span></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Organization and General</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Armada Acquisition Corp. I (the
  &#8220;Company&#8221;) is a newly organized blank check company incorporated as a Delaware corporation on <span id="xdx_90C_edei--EntityIncorporationDateOfIncorporation_c20201106__20210630_zLyTxt1t3jb7" title="Date of incorporation"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" format="ixt:datemonthdayyearen" name="dei:EntityIncorporationDateOfIncorporation">November 5, 2020</ix:nonNumeric></span>. The Company
  was incorporated for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or other similar
  business combination with one or more businesses (the &#8220;Business Combination&#8221;). The Company is in the process of searching
  for a Business Combination target but has not yet selected any specific Business Combination target. The Company intends to concentrate
  its efforts identifying businesses in the financial services industry with particular emphasis on businesses that are providing or changing
  technology for traditional financial services.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of June 30, 2021, the Company
  had not commenced any operations. All activity for the period from November 5, 2020 (inception) through June 30, 2021 relates to the Company&#8217;s
  formation and preparation for the initial public offering (the &#8220;IPO&#8221;). The Company will not generate any operating revenues
  until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the
  form of interest income on cash and cash equivalents from the proceeds derived from the IPO.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has selected September
  30 as its fiscal year end.<span style="color: #252525">&#160;</span></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s sponsor is
  Armada Sponsor LLC (the &#8220;Sponsor&#8221;).</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>Financing</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The registration statement for
  the Company&#8217;s IPO was declared effective on August 12, 2021 (the &#8220;Effective Date&#8221;). On August 17, 2021, the Company
  consummated the IPO of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zPOYHAx5FW6i" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_us-gaap_IPOMember_custom_UnitsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,000,000</ix:nonFraction></span> units at $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_z18nMx1aF6Y5" title="Price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember_us-gaap_IPOMember_custom_UnitsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per unit (the &#8220;Units&#8221;), which is discussed in Note 3.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Simultaneously with the consummation
  of the IPO, the Company consummated the private placement of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementClassOfStockAxis__custom--PrivateSharesMember_zH41Axfn4pTg"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_PrivateSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">459,500</ix:nonFraction></span> shares of common stock (the &#8220;Private Shares&#8221;), at a price
  of $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementClassOfStockAxis__custom--PrivateSharesMember_zmN57YKqpeG1"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_PrivateSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per share for an aggregate purchase price of $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementClassOfStockAxis__custom--PrivateSharesMember_zfyNBOef0eja" title="Aggregate purchase price"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_PrivateSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,595,000</ix:nonFraction></span>.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">At August 17, 2021 related to the IPO, transaction costs amounted to $<span id="xdx_90E_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zF686SChGJDb" title="Transaction costs"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,342,968</ix:nonFraction></span> consisting of $<span id="xdx_907_ecustom--UnderwritingCommissionCosts_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zDFTIQVUJJ1b" title="Underwriting commissions"><ix:nonFraction name="aaciu:UnderwritingCommissionCosts" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500,000</ix:nonFraction></span> of underwriting commissions, and $<span id="xdx_909_ecustom--OtherOfferingCosts_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zO9ia5xbLnm6" title="Other offering costs"><ix:nonFraction name="aaciu:OtherOfferingCosts" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,842,968</ix:nonFraction></span> of other offering costs. In addition, $<span id="xdx_905_eus-gaap--RestrictedCash_iI_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zbH5bju33qj1" title="Cash held outside of Trust Account"><ix:nonFraction name="us-gaap:RestrictedCash" contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,605</ix:nonFraction></span> of cash was held outside of the Trust Account (as defined below) and is available for working capital purposes. After the close of the IPO, paying offering costs and having excess funds released from the trust account, on August 18, 2021, the Company had $<span id="xdx_904_eus-gaap--Cash_iI_c20210818__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zLKE8liWc2" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2021-08-18_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,163,587</ix:nonFraction></span> in cash available for working capital purposes.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>Trust Account</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Following the closing of the IPO
  on August 17, 2021 after releasing funds to the Company to be held outside of the Trust, $<span id="xdx_908_eus-gaap--AssetsHeldInTrust_iI_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zBFUuA8vzhNa" title="Proceeds held in trust account"><ix:nonFraction name="us-gaap:AssetsHeldInTrust" contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,000,000</ix:nonFraction></span> ($<span id="xdx_90C_ecustom--TrustAssetsValuePerShare_iI_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zasnYTOyWZJd" title="Trust assets value per unit"><ix:nonFraction name="aaciu:TrustAssetsValuePerShare" contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Unit) from the net proceeds
  of the sale of the Units in the IPO was held in a trust account (the &#8220;Trust Account&#8221;) and was invested only in U.S. government
  securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the &#8220;Investment
  Company Act&#8221;), having a maturity of <span id="xdx_900_ecustom--MaturityPeriodOfGovernmentSecurities_dtD_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zjlgurllF8C7" title="Maturity period of government securities"><ix:nonNumeric contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt-sec:durday" name="aaciu:MaturityPeriodOfGovernmentSecurities">185</ix:nonNumeric></span> days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated
  under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned
  on the funds held in the Trust Account that may be released to the Company to pay income tax obligations, the proceeds from the IPO and
  the sale of the Private Shares will not be released from the Trust Account until the earlier of the completion of a Business Combination
  or the Company&#8217;s redemption of <span id="xdx_907_ecustom--RedemptionPercentageOfOutstandingShares_uPure_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTRizZt5qMUf" title="Redemption percentage of outstanding shares"><ix:nonFraction name="aaciu:RedemptionPercentageOfOutstandingShares" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span> of the outstanding public shares if it has not completed a Business Combination in the required
  time period The proceeds held in the Trust Account may be used as consideration to pay the sellers of a target business with which the
  Company completes a Business Combination. Any amounts not paid as consideration to the sellers of the target business may be used to finance
  operations of the target business.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>
  
  <ix:exclude><!-- Field: Page; Sequence: 8 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page --></ix:exclude>
  
  <ix:exclude><p id="xdx_23D_zqU1pf92ImAl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p></ix:exclude>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s management
  has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Shares, although
  substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><b>Initial Business
  Combination</b></span></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company must complete one
  or more initial Business Combinations having an aggregate fair market value of at least <span id="xdx_902_ecustom--PercentageOfTrustAssetsForAcquisition_uPure_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zGya6Cb0K0d2" title="Percentage of trust assets for acquisition"><ix:nonFraction name="aaciu:PercentageOfTrustAssetsForAcquisition" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">80</ix:nonFraction>%</span> of the value of the assets held in the Trust
  Account (excluding taxes payable) at the time of the agreement to enter into the initial Business Combination. However, the Company will
  only complete a Business Combination if the post-transaction company owns or acquires <span id="xdx_905_ecustom--PercentageOfOwnershipForAcquisition_uPure_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zVJzOmKahdLc" title="Percentage of ownership for acquisition"><ix:nonFraction name="aaciu:PercentageOfOwnershipForAcquisition" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction>%</span> or more of the outstanding voting securities
  of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment
  company under the Investment Company Act. There is no assurance that the Company will be able to complete a Business Combination successfully.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In connection with any proposed
  Business Combination, the Company will either (1) seek stockholders&#8217; approval of the initial Business Combination at a meeting called
  for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against the proposed Business
  Combination or do not vote at all, into their pro rata share of the aggregate amount then on deposit in the Trust Account (net of taxes
  payable), or (2) provide its stockholders with the opportunity to sell their shares to the Company by means of a tender offer (and thereby
  avoid the need for a stockholder vote) for an amount equal to their pro rata share of the aggregate amount then on deposit in the Trust
  Account (net of taxes payable), in each case subject to the limitations described herein. The decision as to whether the Company will
  seek stockholders&#8217; approval of a proposed Business Combination or will allow stockholders to sell their shares to the Company in
  a tender offer will be made by the Company, solely in its discretion.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The shares of common stock subject
  to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance
  with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; In such case,
  the Company will proceed with a Business Combination if the Company has net tangible assets of at least $<span id="xdx_90B_ecustom--NetTangibleAssetsForAcquisition_iI_dtD_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z9wahSe8PMwj" title="Net tangible assets for acquisition"><ix:nonFraction name="aaciu:NetTangibleAssetsForAcquisition" contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000,001</ix:nonFraction></span> upon such consummation
  of a Business Combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted
  in favor of the Business Combination.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company will have <span id="xdx_908_ecustom--PeriodFromInitialPublicOfferingClosingToCompleteAcquisition_dtM_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zopjDzYoQppf" title="Period from IPO closing to complete acquisition"><ix:nonNumeric contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt-sec:durmonth" name="aaciu:PeriodFromInitialPublicOfferingClosingToCompleteAcquisition">15</ix:nonNumeric></span> months
  (or <span id="xdx_90B_ecustom--ExtendedPeriodFromInitialPublicOfferingClosingToCompleteAcquisition_dtM_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zCmxQQNfUHBd" title="Extended period from IPO closing to complete acquisition"><ix:nonNumeric contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt-sec:durmonth" name="aaciu:ExtendedPeriodFromInitialPublicOfferingClosingToCompleteAcquisition">18</ix:nonNumeric></span> months if extended) from the closing of the IPO to complete the initial Business Combination (the &#8220;Combination Period&#8221;).
  However, if the Company is unable to complete the initial Business Combination within the Combination Period, the Company will (i) cease
  all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter,
  redeem <span id="xdx_90D_ecustom--PercentageOfPublicSharesToBeRedeemed_uPure_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zIOltgOYxmd" title="Percentage of public shares to be redeemed"><ix:nonFraction name="aaciu:PercentageOfPublicSharesToBeRedeemed" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span> of the outstanding public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in
  the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company but net
  of taxes payable (and less up to $<span id="xdx_901_ecustom--InterestAmountToPayDissolutionExpenses_iI_dtD_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zXZseMjKwMn9" title="Interest amount to pay dissolution expenses"><ix:nonFraction name="aaciu:InterestAmountToPayDissolutionExpenses" contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span> of interest to pay dissolution expenses), divided by the number of then outstanding public shares,
  which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further
  liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption,
  subject to the approval of the Company&#8217;s remaining stockholders and the Company&#8217;s board of directors, liquidate and dissolve,
  subject (in the case of (ii) and (iii) above) to the Company&#8217;s obligations under Delaware law to provide for claims of creditors
  and the requirements of other applicable law.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Sponsor, officers and directors
  have agreed (i) to vote any shares owned by them in favor of any proposed Business Combination, (ii) not to redeem any shares in connection
  with a stockholder vote to approve a proposed initial Business Combination or sell any shares to the Company in a tender offer in connection
  with a proposed initial Business Combination, (iii) that the Founder Shares (as defined below) will not participate in any liquidating
  distributions from the Company&#8217;s Trust Account upon winding up if a Business Combination is not consummated.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt; color: #252525">&#160;</p>
  
  
  <ix:exclude><!-- Field: Page; Sequence: 9 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page --></ix:exclude>
  
  <ix:exclude><p id="xdx_234_zFSippqXJyf1" style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&#160;</p></ix:exclude>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Sponsor has agreed that it
  will be liable to ensure that the proceeds in the Trust Account are not reduced below $<span id="xdx_902_ecustom--MinimumTrustProceedsPerShare_iI_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zkQ1dZJKM2f5" title="Minimum trust proceeds per share"><ix:nonFraction name="aaciu:MinimumTrustProceedsPerShare" contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per share by the claims of target businesses
  or claims of vendors or other entities that are owed money by the Company for services rendered or contracted for or products sold to
  the Company. The agreement entered into by the Sponsor specifically provides for two exceptions to the indemnity it has given: it will
  have no liability (1) as to any claimed amounts owed to a target business or vendor or other entity who has executed an agreement with
  the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account, or (2)
  as to any claims for indemnification by the underwriters of the IPO against certain liabilities, including liabilities under the Securities
  Act. However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has it independently verified
  whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor&#8217;s only assets are securities
  of the Company. Therefore, the Company believes it is unlikely that the Sponsor will be able to satisfy its indemnification obligations
  if it is required to do so.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Liquidity and Capital Resources</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of June 30, 2021, the Company
  had approximately $<span id="xdx_90A_eus-gaap--Cash_iI_c20210630_z7QDZrR14vib" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,746</ix:nonFraction></span> in its operating account and working capital deficit of $<span id="xdx_906_ecustom--WorkingCapitalDeficit_iI_c20210630_zkJ8FEswvyib" title="Working capital deficit"><ix:nonFraction name="aaciu:WorkingCapitalDeficit" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,662</ix:nonFraction></span> (which includes deferred offering costs of $<span id="xdx_90A_eus-gaap--DeferredOfferingCosts_iI_c20210630_zx5dT4hmV7Kd"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">168,285</ix:nonFraction></span> that will
  be paid with proceeds from the IPO).</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s liquidity
  needs up to June 30, 2021 had been satisfied through advances from related parties to cover certain offering costs and formation expenses
  of $<span id="xdx_904_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iI_c20210630_zf3U76xVgLe" title="Advances from related parties"><ix:nonFraction name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,352</ix:nonFraction></span> (see Note 5). In order to finance transaction costs in connection with a Business Combination, the Company&#8217;s Sponsor
  or an affiliate of the Sponsor or certain of the Company&#8217;s officers and directors may, but are not obligated to, provide the Company
  with Working Capital Loans, as defined below (see Note 5). As of June 30, 2021, there were no amounts outstanding under any Working Capital
  Loans.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify; text-indent: 0.5in">Subsequent to the period
  covered by this quarterly report on Form 10-Q (the &#8220;Quarterly Report&#8221;), the Company consummated its IPO (see Note 3) and sales
  of the Private Shares (See Note 4). Of the net proceeds from the IPO and the sales of the Private Shares, $<span id="xdx_908_eus-gaap--AssetsHeldInTrust_iI_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zuq61O66cbV4"><ix:nonFraction name="us-gaap:AssetsHeldInTrust" contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,000,000</ix:nonFraction></span> of cash was placed
  in the Trust Account and $<span id="xdx_90F_eus-gaap--RestrictedCash_iI_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_za5NfSIjK7n6"><ix:nonFraction name="us-gaap:RestrictedCash" contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,605</ix:nonFraction></span> of cash was held outside of the Trust Account and is available for the Company&#8217;s working capital
  purposes. After the close of the IPO, paying offering costs and having excess funds released from the trust account, on August 18, 2021,
  the Company had $<span id="xdx_90F_eus-gaap--Cash_iI_c20210818__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zH0F9hGZB986" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2021-08-18_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,163,587</ix:nonFraction></span> in cash available for working capital purposes.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Based on the foregoing, management
  believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation
  of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing
  accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective
  target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating
  and consummating the Business Combination.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Risks and Uncertainties</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Management is continuing to evaluate
  the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a
  negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific
  impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments
  that might result from the outcome of this uncertainty.</p>
  
  </ix:nonNumeric><p id="xdx_819_zGiJ1qBDjWbg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  
  <!-- Field: Page; Sequence: 10 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; color: #252525"><b>&#160;</b></p>
  
  <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80E_eus-gaap--SignificantAccountingPoliciesTextBlock_zq3v0ljRZOPe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b>Note 2 &#8212; <span id="xdx_824_zpoLfDVRuTt7">Significant Accounting
  Policies</span></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt; color: #252525">&#160;</p>
  
  <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_842_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zgBoAICev1Z5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Basis of Presentation</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The accompanying unaudited condensed
  financial statements are presented in conformity with accounting principles generally accepted in the United States of America (&#8220;US
  GAAP&#8221;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). Accordingly,
  they do not include all of the information and footnotes required by US GAAP. In the opinion of management, the unaudited condensed financial
  statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and
  results for the period presented. Operating results for the period from November 5, 2020 (inception) through June 30, 2021 are not necessarily
  indicative of the results that may be expected through September 30, 2021.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The accompanying unaudited condensed
  financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8-K and
  the final prospectus filed by the Company with the SEC on August 24, 2021 and August 16, 2021, respectively.</p>
  
  </ix:nonNumeric><p id="xdx_853_zg8K1XuXHAw4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt; color: #252525">&#160;</p>
  
  <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" escape="true" name="aaciu:EmergingGrowthCompanyStatusPolicyTextBlock"><p id="xdx_84F_ecustom--EmergingGrowthCompanyStatusPolicyTextBlock_zZA0qJrNlHta" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Emerging Growth Company Status</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company is an &#8220;emerging
  growth company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), as modified
  by the Jumpstart the Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from
  various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not
  limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure
  obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding
  a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Further, Section 102(b)(1) of
  the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
  private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
  of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS
  Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
  growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period,
  which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company,
  as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
  This may make comparison of the Company&#8217;s financial statements with the financial statements of another public company which is
  neither an emerging growth company nor an emerging growth company or which has opted out of using the extended transition period difficult
  or impossible because of the potential differences in accounting standards used.</p>
  
  </ix:nonNumeric><p id="xdx_856_zk0w5OF8c7Dc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>
  
  <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_84A_eus-gaap--UseOfEstimates_ziCHWYvRQcDj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Use of Estimates</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements
  in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
  and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during
  the reporting period. Actual results could differ from those estimates.</p>
  
  </ix:nonNumeric><p id="xdx_85E_ztWSzrrRsGn6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt; color: #252525">&#160;</p>
  
  <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z2Oq4nv91Ush" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Cash and Cash Equivalents</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company considers all short-term
  investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $<span id="xdx_900_eus-gaap--Cash_iI_c20210630_z3hv9YPBkwt7" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,746</ix:nonFraction></span> in cash and
  <span id="xdx_908_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20210630_zoWUVcYagZs9" title="Cash equivalents"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2021-06-30" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span> cash equivalents as of June 30, 2021.</p>
  
  </ix:nonNumeric><p id="xdx_855_z47zRv2huEEc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  
  <ix:exclude><!-- Field: Page; Sequence: 11 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page --></ix:exclude>
  
  <ix:exclude><p id="xdx_23B_zHNmjxkRuXvc" style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; color: #252525"><b><i>&#160;</i></b></p></ix:exclude>
  
  <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" escape="true" name="us-gaap:DeferredChargesPolicyTextBlock"><p id="xdx_84C_eus-gaap--DeferredChargesPolicyTextBlock_zzP3OiXpNYn3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Deferred Offering Costs</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Deferred offering costs consist
  of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO and
  that have been charged to stockholders&#8217; equity upon the completion of the IPO.</p>
  
  </ix:nonNumeric><p id="xdx_85F_zJPt4LUBxslj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>&#160;</i></b></p>
  
  <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" escape="true" name="aaciu:AllocationOfProceedsPolicyTextBlock"><p id="xdx_84C_ecustom--AllocationOfProceedsPolicyTextBlock_zPv8dsYI4Tzl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Allocation of Proceeds</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; color: #252525">FASB ASC 470-20,
  Debt with Conversion and Other Options, addresses the allocation of proceeds from the issuance of convertible debt into its equity and
  debt components. The Company applies this guidance to allocate IPO proceeds from the Units between common stock and warrants, using the
  residual method by allocating IPO proceeds first to fair value of the warrants, if any, and then common stock. Any amount paid to investors
  represents a reduction in the proceeds to be allocated.</p>
  
  </ix:nonNumeric><p id="xdx_85E_zsjyWRS6PdRj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #252525">&#160;</p>
  
  <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zJWHbyHQRMb5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Net Loss Per Share</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Net loss per share is computed
  by dividing net loss by the weighted average number of common stock outstanding during the period, excluding common stock subject to forfeiture
  by the Sponsor. Weighted average shares were reduced for the effect of an aggregate of <span id="xdx_90B_eus-gaap--CommonStockOtherSharesOutstanding_iI_c20210630_zbdRPLHZaq47" title="Shares subject to forfeiture"><ix:nonFraction name="us-gaap:CommonStockOtherSharesOutstanding" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">675,000</ix:nonFraction></span> shares of common stock that are subject
  to forfeiture if the over-allotment option is not exercised by the underwriters (see Note 5). At June 30, 2021, the Company did not have
  any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the
  earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.</p>
  
  </ix:nonNumeric><p id="xdx_855_zRPzz5Schmt4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zpoJjWN720Ib" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Fair Value of Financial Instruments</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The fair value of the Company&#8217;s
  assets and liabilities approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term
  nature.</p>
  
  </ix:nonNumeric><p id="xdx_858_znmIXkvGHfcj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt; color: #252525">&#160;</p>
  
  <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_zm4DsezjF54f" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Income Taxes</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company accounts for income
  taxes under ASC 740 Income Taxes (&#8220;ASC 740&#8221;). ASC 740 requires the recognition of deferred tax assets and liabilities for
  both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future
  tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established
  when it is more likely than not that all or a portion of deferred tax assets will not be realized.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">ASC 740 also clarifies the accounting
  for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements and prescribes a recognition threshold and measurement
  process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those
  benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740
  also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company recognizes accrued
  interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts
  accrued for interest and penalties as of June 30, 2021. The Company is currently not aware of any issues under review that could result
  in significant payments, accruals or material deviation from its position.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has identified the
  United States as its only &#8220;major&#8221; tax jurisdiction.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company may be subject to
  potential examination by federal and state taxing authorities in the areas of income taxes since inception. These potential examinations
  may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal
  and state tax laws. The Company&#8217;s management does not expect that the total amount of unrecognized tax benefits will materially
  change over the next twelve months.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  
  
  <ix:exclude><!-- Field: Page; Sequence: 12 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page --></ix:exclude>
  
  <ix:exclude><p id="xdx_233_z40jPvheIMr" style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&#160;</p></ix:exclude>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt"></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The provision for income taxes
  was deemed to be immaterial for the period from November 5, 2020 (inception) through June 30, 2021.</p>
  
  </ix:nonNumeric><p id="xdx_857_zhjPXLQ9O0Rf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt; color: #252525">&#160;</p>
  
  <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zBKYnBBjuyF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Recent Accounting Pronouncements</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In August 2020, the Financial
  Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, Debt &#8212; Debt with
  Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)
  (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require
  separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception
  guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional
  disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06
  amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments.
  ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted
  beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position,
  results of operations or cash flows.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Management does not believe that
  any recently issued, but not effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#8217;s
  unaudited condensed financial statements.</p>
  
  </ix:nonNumeric><p id="xdx_85A_zWWepfOx1Alf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_84A_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z93dypmepsS9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Stock Based Compensation</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On June 16, 2021, the
  Sponsor transferred <span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_c20210615__20210616__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zLheqoZHifoa" title="Shares of common stock transferred"><span id="xdx_904_eus-gaap--ConversionOfStockSharesConverted1_c20210615__20210616__srt--TitleOfIndividualAxis__srt--PresidentMember_z7xrTRs93zV2" title="Shares of common stock transferred"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-06-152021-06-16_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-06-152021-06-16_srt_PresidentMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></ix:nonFraction></span></span>
  shares of common stock to each of its Chief Executive Officer and its President and <span id="xdx_900_eus-gaap--ConversionOfStockSharesConverted1_c20210615__20210616__srt--TitleOfIndividualAxis__srt--DirectorMember_z14pGIPpp0C8"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-06-152021-06-16_srt_DirectorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">35,000</ix:nonFraction></span>
  shares of common stock to each of its <span id="xdx_905_ecustom--NumberOfIndependentDirectors_dc_uDirector_c20210615__20210616__srt--TitleOfIndividualAxis__srt--DirectorMember_zmBkmFxPAIP4" title="Number of independent directors"><ix:nonFraction name="aaciu:NumberOfIndependentDirectors" contextRef="From2021-06-152021-06-16_srt_DirectorMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Director">three</ix:nonFraction></span>
  independent directors. The aggregate fair value of these shares was $<span id="xdx_904_eus-gaap--ConversionOfStockAmountConverted1_c20210615__20210630_zZVy5PCPJ4Qe" title="Fair value of converted shares"><ix:nonFraction name="us-gaap:ConversionOfStockAmountConverted1" contextRef="From2021-06-152021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">509,552</ix:nonFraction></span>
  at June 30, 2021. We recognize compensation expense related to these transfers according to ASC 718-10-25-20 when the performance
  condition associated with these awards is probable of achievement. Since the stock grants contain the performance condition of
  consummating a business combination, the Company believes the appropriate accounting treatment is to defer recognition of the
  compensation costs until the consummation of an initial business combination. At June 30, 2021, <span id="xdx_903_eus-gaap--AllocatedShareBasedCompensationExpense_do_c20210615__20210630_z1Iso7lSZnkk" title="Compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-06-152021-06-30" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span>
  compensation expense was recognized related to these shares.</p>
  
  </ix:nonNumeric><p id="xdx_85A_z2kGtXzJLaAe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; display: none">&#160;</p>
  
  </ix:nonNumeric><p id="xdx_81C_z3gMnjBw1nu9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt">&#160;</p>
  
  <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" escape="true" name="aaciu:InitialPublicOfferingTextBlock"><p id="xdx_80E_ecustom--InitialPublicOfferingTextBlock_zsrhErmaN7Vi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b>Note 3 &#8212; <span id="xdx_82F_zCpI9xYMIfKi">IPO</span></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b>&#160;</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On August 17, 2021, the Company
  consummated its IPO of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zAAnH0CC7mxb" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_us-gaap_IPOMember_custom_UnitsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,000,000</ix:nonFraction></span> Units, at a price of $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zQXdbZqU5X69" title="Price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember_us-gaap_IPOMember_custom_UnitsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Unit. <span id="xdx_90C_eus-gaap--SaleOfStockDescriptionOfTransaction_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_z3LSVHXazlP6" title="Description of Units"><ix:nonNumeric contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_us-gaap_IPOMember_custom_UnitsMember" name="us-gaap:SaleOfStockDescriptionOfTransaction">Each Unit consists of one share of common stock and one-half of
  one redeemable warrant</ix:nonNumeric></span>. Each whole warrant entitles the holder to purchase one share of common stock at a price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zUt0raCsTuue" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember_us-gaap_IPOMember_custom_UnitsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span> per share, subject
  to adjustment. Only whole warrants are exercisable. No fractional warrants will be issued upon separation of the units and only whole
  warrants will trade.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The warrants will become exercisable&#160;<span id="xdx_90A_ecustom--WarrantExercisablePeriodAfterBusinessCombination_dtD_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zQBecqqAKG95" title="Warrant exercisable period after business combination"><ix:nonNumeric contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_us-gaap_IPOMember_custom_UnitsMember" format="ixt-sec:durday" name="aaciu:WarrantExercisablePeriodAfterBusinessCombination">30</ix:nonNumeric></span>
  days after&#160;the completion of the initial Business&#160;Combination, and&#160;will expire <span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dt_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zhrfstFSy3ve" title="Warrant expiration period"><ix:nonNumeric contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember_us-gaap_IPOMember_custom_UnitsMember" format="ixt-sec:durwordsen" name="us-gaap:WarrantsAndRightsOutstandingTerm">five years</ix:nonNumeric></span> after the completion of the initial
  Business Combination or earlier upon redemption or liquidation (see Note 7).</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Following the closing of the IPO
  and settlement of funds on August 17, 2021, <span id="xdx_909_eus-gaap--AssetsHeldInTrust_iI_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5HZ4WcgIPQ3" title="Proceeds held in trust account">$<ix:nonFraction name="us-gaap:AssetsHeldInTrust" contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,000,000</ix:nonFraction></span> ($<span id="xdx_900_ecustom--TrustAssetsValuePerShare_iI_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zIAnTqAZ4us3" title="Trust assets value per unit"><ix:nonFraction name="aaciu:TrustAssetsValuePerShare" contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Unit) from the net proceeds of the sale of the Units in the IPO and
  the sales of Private Shares was placed in the Trust Account and will be invested only in U.S. government treasury obligations with a maturity
  of <span id="xdx_90B_ecustom--MaturityPeriodOfGovernmentSecurities_dtD_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zNoqRUGimpU6" title="Maturity period of government securities"><ix:nonNumeric contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt-sec:durday" name="aaciu:MaturityPeriodOfGovernmentSecurities">185</ix:nonNumeric></span> days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest
  only in direct U.S. government treasury obligations.</p>
  
  </ix:nonNumeric><p id="xdx_816_zWGNNykwt6i9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt; color: #252525">&#160;</p>
  
  <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" escape="true" name="aaciu:PrivatePlacementTextBlock"><p id="xdx_800_ecustom--PrivatePlacementTextBlock_zmH9lvnYNBq3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b>Note 4 &#8212; <span id="xdx_82A_zSR028qovbKf">Private Placement</span></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Simultaneously with the closing
  of the IPO, the Sponsor purchased an aggregate of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementClassOfStockAxis__custom--PrivateSharesMember_zW7hQGadIDbb" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_PrivateSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">459,500</ix:nonFraction></span> Private Shares, at a price of $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementClassOfStockAxis__custom--PrivateSharesMember_zGSareST4w9j" title="Price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_PrivateSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Private Share, for an aggregate purchase
  price of $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementClassOfStockAxis__custom--PrivateSharesMember_zqOuUggS0KRd" title="Aggregate purchase price"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_PrivateSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,595,000</ix:nonFraction></span> in a private placement. The proceeds from the sale of the Private Shares was added to the proceeds of the IPO and
  placed in the Trust Account. If the Company does not complete an initial Business Combination within the Combination Period, the proceeds
  from the sale of the Private Shares will be included in the liquidating distribution to the public stockholders and the Private Shares
  will be worthless.</p>
  
  </ix:nonNumeric><p id="xdx_816_zJYNlCfI7up2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  
  <!-- Field: Page; Sequence: 13 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; color: #252525"><b>&#160;</b></p>
  
  <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_80D_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zhb7vsr9fXGl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b>Note 5 &#8212; <span id="xdx_827_zHYsLPBNKD0i">Related Party Transactions</span></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Founder Shares</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On February 3, 2021, a
  related party to the Sponsor paid $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210202__20210203__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zPCfEHvNZmwg" title="Value of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-02-022021-02-03_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></span>,
  or approximately $<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_c20210203__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zJVuZJDwOof9" title="Price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-02-03_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.006</ix:nonFraction></span>
  per share, to cover certain offering costs in consideration for <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210202__20210203__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_z72Mk19GE496" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-02-022021-02-03_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,312,500</ix:nonFraction></span>
  shares of common stock, par value $<span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210203__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zUC4NxDUnsn8" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-02-03_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span>
  (the &#8220;Founder Shares&#8221;). On June 16, 2021, the Sponsor purchased an additional <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210615__20210616__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zWXreC48MCK2"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-06-152021-06-16_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">700,000</ix:nonFraction></span>
  Founder Shares at a purchase price of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20210616__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_z0HMxHipG10f"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-06-16_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.006</ix:nonFraction></span>
  per share and transferred <span id="xdx_908_eus-gaap--ConversionOfStockSharesConverted1_c20210615__20210616__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zg2KgxwOZrZa" title="Shares of common stock transferred"><span id="xdx_902_eus-gaap--ConversionOfStockSharesConverted1_c20210615__20210616__srt--TitleOfIndividualAxis__srt--PresidentMember_zsbKX0TdV0Gf" title="Shares of common stock transferred"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-06-152021-06-16_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-06-152021-06-16_srt_PresidentMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></ix:nonFraction></span></span>
  Founder Shares to each of its Chief Executive Officer and its President and <span id="xdx_904_eus-gaap--ConversionOfStockSharesConverted1_c20210615__20210616__srt--TitleOfIndividualAxis__srt--DirectorMember_zJxO2nyZyVr3"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-06-152021-06-16_srt_DirectorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">35,000</ix:nonFraction></span>
  Founder Shares to each of its <span id="xdx_90E_ecustom--NumberOfIndependentDirectors_dc_uDirector_c20210615__20210616__srt--TitleOfIndividualAxis__srt--DirectorMember_zWscgEFpSA35" title="Number of independent directors"><ix:nonFraction name="aaciu:NumberOfIndependentDirectors" contextRef="From2021-06-152021-06-16_srt_DirectorMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Director">three</ix:nonFraction></span>
  independent directors. We recognize compensation expense related to these transfers according to ASC 718-10-25-20 when the
  performance condition associated with these awards is probable of achievement. Since the stock grants contain the performance
  condition of consummating a business combination, the Company believes the appropriate accounting treatment is to defer recognition
  of the compensation costs until the consummation of an initial business combination. At June 30, 2021, the Founder Shares include an
  aggregate of up to <span id="xdx_902_eus-gaap--CommonStockOtherSharesOutstanding_iI_c20210630_zNZRU9vL2iOi" title="Shares subject to forfeiture"><ix:nonFraction name="us-gaap:CommonStockOtherSharesOutstanding" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">675,000</ix:nonFraction></span>
  shares subject to forfeiture by the Sponsor to the extent that the underwriters&#8217; over-allotment option is not exercised in
  full or in part.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Sponsor, officers and directors
  have agreed not to transfer, assign or sell any Founder Shares held by them until the earliest of (A) <span id="xdx_90D_ecustom--PeriodAfterBusinessCombinationForTransferOfShares_dtD_c20201106__20210630__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zvmdPyMzmOR8" title="Period after business combination for transfer of shares"><ix:nonNumeric contextRef="From2020-11-062021-06-30_custom_FounderSharesMember" format="ixt-sec:durday" name="aaciu:PeriodAfterBusinessCombinationForTransferOfShares">180</ix:nonNumeric></span> days after the completion of
  the initial Business Combination and (B) subsequent to the initial Business Combination, the date on which the Company completes a liquidation,
  merger, stock exchange, reorganization or other similar transaction that results in all of the public stockholders having the right to
  exchange their public shares for cash, securities or other property.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Additionally, upon consummation
  of the IPO, the Sponsor sold membership interests in the Sponsor to <span id="xdx_908_ecustom--NumberOfAnchorInvestors_dc_uInvestor_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zdKSLlk3ZPw4" title="Number of anchor investors"><ix:nonFraction name="aaciu:NumberOfAnchorInvestors" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_custom_UnitsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Investor">10</ix:nonFraction></span> anchor investors that purchased <span id="xdx_906_ecustom--PercentageOfUnitsPurchasedByAnchorInvestors_uPure_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zTa6JxJUaZ" title="Percentage of units purchased by anchor investors"><ix:nonFraction name="aaciu:PercentageOfUnitsPurchasedByAnchorInvestors" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_us-gaap_IPOMember_custom_UnitsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.9</ix:nonFraction>%</span> of the units sold in the IPO.
  The Sponsor sold membership interests in the Sponsor reflecting an allocation of <span id="xdx_901_ecustom--StockAllocatedToEachAnchorInvestorShares_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zfz62RhLhcqi" title="Stock allocated to each anchor investor, shares"><ix:nonFraction name="aaciu:StockAllocatedToEachAnchorInvestorShares" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">131,250</ix:nonFraction></span> Founder Shares to each anchor investor, or an
  aggregate of <span id="xdx_90D_ecustom--StockAllocatedToAnchorInvestorsShares_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zwVpt7o2ac" title="Stock allocated to anchor investors, shares"><ix:nonFraction name="aaciu:StockAllocatedToAnchorInvestorsShares" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,312,500</ix:nonFraction></span> Founder Shares to all <span id="xdx_901_ecustom--NumberOfAnchorInvestors_dc_uInvestor_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_z5lzzOwjfE2j"><ix:nonFraction name="aaciu:NumberOfAnchorInvestors" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Investor">10</ix:nonFraction></span> anchor investors, at a purchase price of approximately $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zSdQZQn5fxPc"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.006</ix:nonFraction></span> per share. The Company estimated
  the aggregate fair value of these Founder Shares attributable to each anchor investor to be $<span id="xdx_90F_ecustom--StockAllocatedToEachAnchorInvestorValue_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zYNMcUHar9Hl" title="Stock allocated to each anchor investor, value"><ix:nonFraction name="aaciu:StockAllocatedToEachAnchorInvestorValue" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">424,491</ix:nonFraction></span>, or $<span id="xdx_90D_ecustom--StockAllocatedToEachAnchorInvestorValuePerShare_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zgvZ1722XzRa" title="Stock allocated to each anchor investor, value per share"><ix:nonFraction name="aaciu:StockAllocatedToEachAnchorInvestorValuePerShare" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.23</ix:nonFraction></span> per share. The Company
  has offset the excess of the fair value against the gross proceeds from these anchor investors as a reduction in its additional paid-in
  capital in accordance with Staff Accounting Bulletin Topic 5A.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Representative&#8217;s Common
  Stock</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On February 8, 2021, EarlyBirdCapital,
  Inc. (&#8220;EBC&#8221;) and Northland Securities, Inc. (&#8220;Northland&#8221;) purchased <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesOther_c20210207__20210208__us-gaap--StatementClassOfStockAxis__custom--RepresentativeSharesMember__srt--CounterpartyNameAxis__custom--EarlyBirdCapitalIncMember_z5AZZLmBPdGj" title="Issuance of Representative shares, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2021-02-072021-02-08_custom_RepresentativeSharesMember_custom_EarlyBirdCapitalIncMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">162,500</ix:nonFraction></span> and <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesOther_c20210207__20210208__us-gaap--StatementClassOfStockAxis__custom--RepresentativeSharesMember__srt--CounterpartyNameAxis__custom--NorthlandSecuritiesIncMember_zPA5Pm6FAwU3"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2021-02-072021-02-08_custom_RepresentativeSharesMember_custom_NorthlandSecuritiesIncMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">87,500</ix:nonFraction></span> shares of common stock
  (&#8220;representative shares&#8221;), respectively, at an average purchase price of approximately $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20210208__us-gaap--StatementClassOfStockAxis__custom--RepresentativeSharesMember_zNlY9K09C62d"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-02-08_custom_RepresentativeSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share, or an aggregate
  purchase price of $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueOther_c20210207__20210208__us-gaap--StatementClassOfStockAxis__custom--RepresentativeSharesMember_zU6eVkEIdKT9" title="Issuance of Representative shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2021-02-072021-02-08_custom_RepresentativeSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25.00</ix:nonFraction></span>. On May 29, 2021, Northland returned <span id="xdx_907_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_c20210528__20210529__us-gaap--StatementClassOfStockAxis__custom--RepresentativeSharesMember__srt--CounterpartyNameAxis__custom--NorthlandSecuritiesIncMember_zhstPGEPzz8a" title="Representative shares returned to the Company"><ix:nonFraction name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" contextRef="From2021-05-282021-05-29_custom_RepresentativeSharesMember_custom_NorthlandSecuritiesIncMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">87,500</ix:nonFraction></span> shares of common stock to the Company, for no consideration, which
  shares were subsequently cancelled.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The representative shares are
  identical to the public shares included in the Units that were sold in the IPO, except that the representative shares are subject to certain
  transfer restrictions, as described in more detail below.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The holders of the representative
  shares have agreed not to transfer, assign or sell any such shares until <span id="xdx_909_ecustom--PeriodAfterBusinessCombinationForTransferOfShares_dtD_c20201106__20210630__us-gaap--StatementClassOfStockAxis__custom--RepresentativeSharesMember_zIB5sk9yj0F1"><ix:nonNumeric contextRef="From2020-11-062021-06-30_custom_RepresentativeSharesMember" format="ixt-sec:durday" name="aaciu:PeriodAfterBusinessCombinationForTransferOfShares">30</ix:nonNumeric></span> days after the completion of an initial Business Combination.
  In addition, the holders of the representative shares have agreed (i)&#160;to waive their redemption rights (or right to participate in
  any tender offer) with respect to such shares in connection with the completion of an initial Business Combination and (ii)&#160;to waive
  their rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete an initial
  Business Combination within the Combination Period.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Promissory Note&#8212;Related
  Party</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On February 3, 2021, the Sponsor
  agreed to loan the Company up to $<span id="xdx_902_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20210203__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z4qAhql1twN3" title="Maximum amount agreed to loan"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2021-02-03_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></span> to be used for a portion of the expenses of the IPO. These loans are non-interest bearing, unsecured
  and are due at the earlier of <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_c20210629__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zRxCQLg2L1Kk" title="Debt maturity date"><ix:nonNumeric contextRef="From2021-06-292021-06-30_custom_SponsorMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">October 31, 2021</ix:nonNumeric></span> or the closing of the IPO. As of June 30, 2021, the Company had $<span id="xdx_906_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iI_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zTakgnUb2bO" title="Advances from related parties"><ix:nonFraction name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" contextRef="AsOf2021-06-30_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,352</ix:nonFraction></span> of borrowings under
  the promissory note.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Due from Sponsor</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of June 30, 2021, the Company
  was due from the Sponsor $<span id="xdx_904_eus-gaap--DueFromAffiliates_iI_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zKo4WKHm1MCc" title="Due from Sponsor"><ix:nonFraction name="us-gaap:DueFromAffiliates" contextRef="AsOf2021-06-30_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,070</ix:nonFraction></span> for the purchase of the Founder Shares.&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  
  <ix:exclude><!-- Field: Page; Sequence: 14 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page --></ix:exclude>
  
  <ix:exclude><p id="xdx_234_zV1bY8Gamf5d" style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; color: #252525"><b><i>&#160;</i></b></p></ix:exclude>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Working Capital Loans</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In order to meet the Company&#8217;s
  working capital needs following the consummation of the IPO, the Sponsor, officers, directors or their affiliates may, but are not obligated
  to, loan the Company funds (&#8220;Working Capital Loans&#8221;), from time to time or at any time, in whatever amount they deem reasonable
  in their sole discretion. Each loan would be non-interest bearing and be evidenced by a promissory note. The notes would either be paid
  upon consummation of the initial Business Combination, without interest, or, at holder&#8217;s discretion, up to $<span id="xdx_903_eus-gaap--DebtConversionOriginalDebtAmount1_c20210629__20210630__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoansMember_zgAusBeYWHo1" title="Loan amount convertible into common stock"><ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2021-06-292021-06-30_custom_WorkingCapitalLoansMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500,000</ix:nonFraction></span> of the notes
  may be converted into shares of common stock at a price of $<span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210630__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoansMember_zxPgXNG3qGCl" title="Loan conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2021-06-30_custom_WorkingCapitalLoansMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per share. The shares would be identical to the Private Shares. In the
  event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust
  Account to repay such loaned amounts, but no proceeds from the Trust Account would be used for such repayment.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Administrative Service Fee</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Commencing on the Effective
  Date, the Company will pay the Sponsor $<span id="xdx_90E_eus-gaap--RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zi9gXJMJ659d" title="Monthly fee"><ix:nonFraction name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000</ix:nonFraction></span>
  per month for office space, utilities and secretarial support. Upon completion of the initial Business Combination or the
  Company&#8217;s liquidation, the Company will cease paying these monthly fees.</p>
  
  </ix:nonNumeric><p id="xdx_81C_zQkMR6VXJgQf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>
  
  <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80F_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zmtUwXja4rk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b>Note 6 &#8212; <span id="xdx_82B_z2JKC7XhxKv5">Commitments and
  Contingencies</span></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Registration Rights</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b>&#160;</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The holders of the Founder Shares
  issued and outstanding on the date of the IPO, as well as the holders of the representative shares, Private Shares and any shares the
  Company&#8217;s Sponsor, officers, directors or their affiliates may issue in payment of Working Capital Loans made to the Company, will
  be entitled to registration rights pursuant to an agreement signed on the Effective Date. The holders of
  a majority of these securities (other than the holders of the representative shares) are entitled to make up to two demands that the Company
  registers such securities. The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time
  commencing three months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority
  of the Private Shares and shares issued to the Company&#8217;s Sponsor, officers, directors or their affiliates in payment of Working
  Capital Loans made to the Company can elect to exercise these registration rights at any time after the Company consummates a Business
  Combination. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements
  filed subsequent to the Company&#8217;s consummation of a Business Combination. The Company will bear the expenses incurred in connection
  with the filing of any such registration statements.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Underwriting Agreement</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company granted the underwriters
  a <span id="xdx_904_ecustom--PeriodOfUnderwritersOverallotmentsOption_dtD_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zb1QAELTPB02" title="Period of underwriters&apos; over-allotments option"><ix:nonNumeric contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt-sec:durday" name="aaciu:PeriodOfUnderwritersOverallotmentsOption">45</ix:nonNumeric></span>-day option from the date of the IPO to purchase up to an additional <span id="xdx_90F_ecustom--NumberOfSharesAvailableUnderUnderwritersOverallotmentsOption_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zqOT1Tc3fGm5" title="Number of shares available under underwriters&apos; over-allotments option"><ix:nonFraction name="aaciu:NumberOfSharesAvailableUnderUnderwritersOverallotmentsOption" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,250,000</ix:nonFraction></span> units to cover over-allotments, if any.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The underwriters were paid a cash
  underwriting discount of <span id="xdx_90B_ecustom--UnderwritingDiscountPercentage_uPure_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zx6kMKkjSxb2" title="Underwriting discount percentage"><ix:nonFraction name="aaciu:UnderwritingDiscountPercentage" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.0</ix:nonFraction>%</span> of the gross proceeds of the IPO, or <span id="xdx_901_ecustom--UnderwritingCommissionCosts_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zvUON5x1Rvac" title="Underwriting commissions">$<ix:nonFraction name="aaciu:UnderwritingCommissionCosts" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500,000</ix:nonFraction></span> (and are entitled to an additional $<span id="xdx_903_ecustom--DeferredUnderwritingCommissionPayable_iI_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zfZdmgMnjsXf" title="Deferred underwriting commission payable"><ix:nonFraction name="aaciu:DeferredUnderwritingCommissionPayable" contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">225,000</ix:nonFraction></span> of deferred
  underwriting commission payable at the time of an initial Business Combination if the underwriters&#8217; over-allotment is exercised
  in full).</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>&#160;</i></b></p>
  
  
  <ix:exclude><!-- Field: Page; Sequence: 15 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page --></ix:exclude>
  
  <ix:exclude><p id="xdx_23E_zj19WqxcplSl" style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; color: #252525"><b><i>&#160;</i></b></p></ix:exclude>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Financial Advisory Fee</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has engaged Cohen
  &amp; Company Capital Markets, a division of J.V.B. Financial Group, LLC (&#8220;CCM&#8221;), an affiliate of a member of the Sponsor,
  to provide consulting and advisory services in connection with the IPO, for which it will receive an advisory fee equal to one (<span id="xdx_904_ecustom--AdvisoryFeePercentageForIntitialPublicOffering_dp_uPure_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUmuXpzrVD6k" title="Advisory fee percentage for IPO"><ix:nonFraction name="aaciu:AdvisoryFeePercentageForIntitialPublicOffering" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.0</ix:nonFraction></span>) percent
  of the aggregate proceeds of the IPO, or $<span id="xdx_90C_ecustom--AdvisoryFeeForIPOAmountIfUnderwritersOptionIsNotExercised_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zlkfdz5NFom9" title="Advisory fee for IPO amount if underwriters&apos; option is not exercised"><ix:nonFraction name="aaciu:AdvisoryFeeForIPOAmountIfUnderwritersOptionIsNotExercised" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500,000</ix:nonFraction></span> (or up to $<span id="xdx_90E_ecustom--AdvisoryFeeForIPOAmountIfUnderwritersOptionIsExercised_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zZCxQSEXPZ7j" title="Advisory fee for IPO amount if underwriters&apos; option is exercised in full"><ix:nonFraction name="aaciu:AdvisoryFeeForIPOAmountIfUnderwritersOptionIsExercised" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,725,000</ix:nonFraction></span> if the underwriters&#8217; over-allotment is exercised in full),
  upon closing of the IPO. Affiliates of CCM have and manage investment vehicles with a passive investment in the Sponsor. On August 18,
  2021, the Company paid to CCM in aggregate of $<span id="xdx_90B_eus-gaap--PaymentsForFees_c20210816__20210818__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zuFP98bquD89" title="Advisory fee paid"><ix:nonFraction name="us-gaap:PaymentsForFees" contextRef="From2021-08-162021-08-18_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500,000</ix:nonFraction></span>. CCM has agreed to defer the payment of the portion of the advisory fee attributable
  to over-allotment option until the consummation of the initial Business Combination. CCM is engaged to represent the Company&#8217;s interests
  only. CCM is not participating in the IPO as defined in FINRA Rule 5110(j)(16); it is acting as an independent financial adviser as defined
  in FINRA Rule 5110(j)(9). As such, CCM is not acting as an underwriter in connection with the IPO, it will not identify or solicit potential
  investors in the IPO or otherwise be involved in the distribution of the IPO. The Company will also engage CCM as an advisor in connection
  with the initial Business Combination for which it will earn an advisory fee of <span id="xdx_90F_ecustom--AdvisoryFeePercentageForBusinessCombination_uPure_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zjbuWomvwwe2" title="Advisory fee percentage for business combination"><ix:nonFraction name="aaciu:AdvisoryFeePercentageForBusinessCombination" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.25</ix:nonFraction>%</span> of the gross proceeds of the IPO, or $<span id="xdx_901_ecustom--AdvisoryFeeForBusinessCombinationAmountIfUnderwritersOptionIsNotExercised_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0dondwCB7Sd"><ix:nonFraction name="aaciu:AdvisoryFeeForBusinessCombinationAmountIfUnderwritersOptionIsNotExercised" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,375,000</ix:nonFraction></span>
  (or up to $<span id="xdx_90C_ecustom--AdvisoryFeeForBusinessCombinationAmountIfUnderwritersOptionIsExercised_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zVGYz3wxmYU2"><ix:nonFraction name="aaciu:AdvisoryFeeForBusinessCombinationAmountIfUnderwritersOptionIsExercised" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,881,250</ix:nonFraction></span> if the underwriters&#8217; over-allotment is exercised in full), payable at closing of the Business Combination.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="color: #252525"><b><i>Business Combination
  Marketing Agreement</i></b></span>&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company will engage the representative
  of the underwriter as an advisor in connection with the initial Business Combination to assist in holding meetings with the Company&#8217;s
  stockholders to discuss the potential Business Combination and the target business&#8217;s attributes, introduce the Company to potential
  investors that are interested in purchasing the Company&#8217;s securities in connection with the initial Business Combination and assist
  the Company with press releases and public filings in connection with the Business Combination. The Company will pay the representative
  a cash fee for such services upon the consummation of the initial Business Combination in an amount equal to <span id="xdx_90E_ecustom--MarketingAgreementFeePercentageForBusinessCombination_uPure_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdixzHM7TgG4"><ix:nonFraction name="aaciu:MarketingAgreementFeePercentageForBusinessCombination" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.25</ix:nonFraction>%</span> of the gross proceeds
  of the IPO, or $<span id="xdx_907_ecustom--MarketingAgreementFeeForBusinessCombinationAmountIfUnderwritersOptionIsNotExercised_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdVvsAsTb6S6"><ix:nonFraction name="aaciu:MarketingAgreementFeeForBusinessCombinationAmountIfUnderwritersOptionIsNotExercised" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,375,000</ix:nonFraction></span> (or up to $<span id="xdx_903_ecustom--MarketingAgreementFeeForBusinessCombinationAmountIfUnderwritersOptionIsExercised_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdskUo0nzEH9"><ix:nonFraction name="aaciu:MarketingAgreementFeeForBusinessCombinationAmountIfUnderwritersOptionIsExercised" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,881,250</ix:nonFraction></span> if the underwriters&#8217; over-allotment is exercised in full). The Company will also
  pay the representative a separate capital market advisory fee of $<span id="xdx_90E_ecustom--CapitalMarketAdvisoryFeeForBusinessCombination_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zi6o83RUGwM1"><ix:nonFraction name="aaciu:CapitalMarketAdvisoryFeeForBusinessCombination" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,500,000</ix:nonFraction></span> upon completion of the initial Business Combination. Additionally,
  the Company will pay the representative a cash fee equal to <span id="xdx_903_ecustom--CashFeePercentageForTargetBusinessIntroductionInBusinessCombination_uPure_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zzK7f83IyYv3"><ix:nonFraction name="aaciu:CashFeePercentageForTargetBusinessIntroductionInBusinessCombination" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.0</ix:nonFraction>%</span> of the total consideration payable in the proposed Business Combination
  if the representative introduces the Company to the target business with which the Company completes a Business Combination; provided
  that the foregoing fee will not be paid prior to the date that is <span id="xdx_90A_ecustom--PeriodFromIPOForPaymentOfCashFeeForTargetBusinessIntroductionInBusinessCombination_dtD_uPure_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z17YsxCIGFd2" title="Period from IPO for payment of cash fee for target business introduction"><ix:nonNumeric contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember" format="ixt-sec:durday" name="aaciu:PeriodFromIPOForPaymentOfCashFeeForTargetBusinessIntroductionInBusinessCombination">60</ix:nonNumeric></span> days from the date of the prospectus for the Company&#8217;s IPO,
  unless such payment would not be deemed underwriters&#8217; compensation in connection with this offering pursuant to FINRA Rule&#160;5110.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b><i>Right of First Refusal</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If the Company determines to pursue
  any equity, equity-linked, debt or mezzanine financing relating to or in connection with an initial Business Combination, then Northland
  shall have the right, but not the obligation, to act as book running manager, placement agent and/or arranger, as the case may be, in
  any and all such financing or financings. This right of first refusal extends from the date of the IPO until the earlier of the consummation
  of an initial Business Combination or the liquidation of the Trust Account if the Company fails to consummate a Business Combination during
  the required time period.</p>
  
  </ix:nonNumeric><p id="xdx_815_zMwd0ApMubL4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt; color: #252525">&#160;</p>
  
  <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_804_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zh23X0uR5vYb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b>Note 7 &#8212; <span id="xdx_82D_zEj0SeT41kSc">Stockholders&#8217;
  Equity</span></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Preferred stock</i></b>&#8212;The
  Company is authorized to issue <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20210630_z7vhh0HS1n7i" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> shares of preferred stock with a par value of $<span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20210630_zQ16bHnQPwx4" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> and with such designations, voting and
  other rights and preferences as may be determined from time to time by the Company&#8217;s board of directors. As of June 30, 2021, there
  were <span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_do_c20210630_zOVzONWnG0gh" title="Preferred stock, shares issued"><span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20210630_zj0Q0XiFUTwc" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-06-30" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-06-30" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></span></span> shares of preferred stock issued or outstanding.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Common stock</i></b>&#8212;The
  Company is authorized to issue <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_c20210630_zn1OZQOONkLf" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></span> shares of common stock with a par value of $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210630_zAsVUFSdusy5" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share. At June 30, 2021, there were
  <span id="xdx_901_eus-gaap--CommonStockSharesIssued_iI_do_c20210630_z5lsHFg0gAw8" title="Common stock, shares issued"><span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_do_c20210630_zi786ywyulCc" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,175,000</ix:nonFraction></ix:nonFraction></span></span> shares of common stock issued and outstanding. On February 3, 2021, affiliates of the Sponsor paid $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210202__20210203__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zzFPrcTIUq67" title="Value of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-02-022021-02-03_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></span>, or approximately
  $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_c20210203__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_z8GWLYBmPGag" title="Price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-02-03_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.006</ix:nonFraction></span> per share, to cover certain offering costs in consideration for <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210202__20210203__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zD5ITn3zLbna" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-02-022021-02-03_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,312,500</ix:nonFraction></span> Founder Shares. On February 8, 2021, EarlyBirdCapital,
  Inc. and Northland purchased <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesOther_c20210207__20210208__us-gaap--StatementClassOfStockAxis__custom--RepresentativeSharesMember__srt--CounterpartyNameAxis__custom--EarlyBirdCapitalIncMember_zWhV1uujESJ7" title="Issuance of Representative shares, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2021-02-072021-02-08_custom_RepresentativeSharesMember_custom_EarlyBirdCapitalIncMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">162,500</ix:nonFraction></span> and <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesOther_c20210207__20210208__us-gaap--StatementClassOfStockAxis__custom--RepresentativeSharesMember__srt--CounterpartyNameAxis__custom--NorthlandSecuritiesIncMember_zBwMnZhfy3S2"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2021-02-072021-02-08_custom_RepresentativeSharesMember_custom_NorthlandSecuritiesIncMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">87,500</ix:nonFraction></span> representative shares, respectively, at an average purchase price of approximately $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20210208__us-gaap--StatementClassOfStockAxis__custom--RepresentativeSharesMember_zWEhSbSb00ma"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-02-08_custom_RepresentativeSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span>
  per share, or an aggregate purchase price of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueOther_c20210207__20210208__us-gaap--StatementClassOfStockAxis__custom--RepresentativeSharesMember_zXqh62Up6v13" title="Issuance of Representative shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2021-02-072021-02-08_custom_RepresentativeSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25.00</ix:nonFraction></span>.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>
  
  <ix:exclude><!-- Field: Page; Sequence: 16 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page --></ix:exclude>
  
  <ix:exclude><p id="xdx_23E_zhuLzAHgRJH" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p></ix:exclude>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On May 29, 2021, Northland returned
  <span id="xdx_90B_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_c20210528__20210529__us-gaap--StatementClassOfStockAxis__custom--RepresentativeSharesMember__srt--CounterpartyNameAxis__custom--NorthlandSecuritiesIncMember_zn5DQXhPvJ81" title="Representative shares returned to the Company"><ix:nonFraction name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" contextRef="From2021-05-282021-05-29_custom_RepresentativeSharesMember_custom_NorthlandSecuritiesIncMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">87,500</ix:nonFraction></span> shares of common stock to the Company, for no consideration, which were subsequently cancelled and on June 16, 2021, the Sponsor
  purchased an additional <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210615__20210616__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zsq7PQgjX6g9"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-06-152021-06-16_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">700,000</ix:nonFraction></span> shares of common stock at a purchase price of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20210616__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_z11cTUDadVia"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-06-16_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.006</ix:nonFraction></span> per share, resulting in the Sponsor holding an aggregate
  of <span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20210616__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z9yYpaFluVMa" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-06-16_custom_FounderSharesMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,012,500</ix:nonFraction></span> shares of common stock. On June 16, 2021, the Sponsor transferred <span id="xdx_906_eus-gaap--ConversionOfStockSharesConverted1_c20210615__20210616__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zoMXcNokQOD5" title="Shares of common stock transferred"><span id="xdx_90A_eus-gaap--ConversionOfStockSharesConverted1_c20210615__20210616__srt--TitleOfIndividualAxis__srt--PresidentMember_zxPP5PCW5B7k" title="Shares of common stock transferred"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-06-152021-06-16_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-06-152021-06-16_srt_PresidentMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></ix:nonFraction></span></span> shares to each of its Chief Executive Officer and
  its President and <span id="xdx_905_eus-gaap--ConversionOfStockSharesConverted1_c20210615__20210616__srt--TitleOfIndividualAxis__srt--DirectorMember_zsR0AnuYBT51"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-06-152021-06-16_srt_DirectorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">35,000</ix:nonFraction></span> shares to each of its <span id="xdx_900_ecustom--NumberOfIndependentDirectors_dc_uDirector_c20210615__20210616__srt--TitleOfIndividualAxis__srt--DirectorMember_zHWO89FYANcl" title="Number of independent directors"><ix:nonFraction name="aaciu:NumberOfIndependentDirectors" contextRef="From2021-06-152021-06-16_srt_DirectorMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Director">three</ix:nonFraction></span> independent directors. At June 30, 2021, the Founder Shares include an aggregate
  of up to <span id="xdx_904_eus-gaap--CommonStockOtherSharesOutstanding_iI_c20210630_z8GzpVGz3uc2" title="Shares subject to forfeiture"><ix:nonFraction name="us-gaap:CommonStockOtherSharesOutstanding" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">675,000</ix:nonFraction></span> shares subject to forfeiture by the Sponsor to the extent that the underwriters&#8217; over-allotment option is not exercised
  in full or in part.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Common stockholders of record
  are entitled to <span id="xdx_90D_eus-gaap--CommonStockVotingRights_c20201106__20210630_zuFmDl9HE7X1" title="Common stock voting rights"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" name="us-gaap:CommonStockVotingRights">one vote for each share</ix:nonNumeric></span> held on all matters to be voted on by stockholders. In connection with any vote held to approve
  the initial Business Combination, the Sponsor, as well as all of the Company&#8217;s officers and directors, have agreed to vote their
  respective shares of common stock owned by them immediately prior to the IPO and any shares purchased in the IPO or following the IPO
  in the open market in favor of the proposed Business Combination.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt; color: #252525">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Warrants</i></b>&#8212;Each
  whole warrant entitles the holder to purchase one share of common stock at a price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210630_zCE1y9auMOh7" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span> per share, subject to adjustment as discussed
  herein. The warrants will become&#160;exercisable <span id="xdx_90D_ecustom--WarrantExercisablePeriodAfterBusinessCombination_dtD_c20201106__20210630_zHzIBvtqwcPi" title="Warrant exercisable period after business combination"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" format="ixt-sec:durday" name="aaciu:WarrantExercisablePeriodAfterBusinessCombination">30</ix:nonNumeric></span>&#160;days after the completion of the Company&#8217;s initial Business Combination.
  However, no warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the
  shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of common stock. Notwithstanding
  the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the public warrants is not effective
  within <span id="xdx_90A_ecustom--WarrantCashlessExercisePeriodAfterBusinessCombination_dtD_c20201106__20210630_zHcR6IyOPLd9"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" format="ixt-sec:durday" name="aaciu:WarrantCashlessExercisePeriodAfterBusinessCombination">90</ix:nonNumeric></span> days following the consummation of the initial Business Combination, warrant holders may, until such time as there is an effective
  registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise
  warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption
  is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless
  basis. In the event of such cashless exercise, each holder would pay the exercise price by surrendering the warrants for that number of
  shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the
  warrants, multiplied by the difference between the exercise price of the warrants and the &#8220;fair market value&#8221; (defined below)
  by (y) the fair market value. The &#8220;fair market value&#8221; for this purpose will mean the average reported last sale price of the
  shares of common stock for the <span id="xdx_906_ecustom--PeriodOfTradingDaysToDetermineFairMarketValueOfCommonStock_dtD_c20201106__20210630_zzt2oCj18CVb"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" format="ixt-sec:durday" name="aaciu:PeriodOfTradingDaysToDetermineFairMarketValueOfCommonStock">5</ix:nonNumeric></span> trading days ending on the trading day prior to the date of exercise. The warrants will expire on the
  fifth anniversary of the completion of an initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or
  liquidation.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
    <tr style="vertical-align: top">
      <td style="width: 3%; padding-top: 2.4pt; padding-right: 8pt; padding-left: 15pt">&#160;</td>
      <td style="width: 97%; padding-top: 2.4pt; padding-right: 2.4pt; padding-left: 2.4pt"><span style="font: 10pt Times New Roman, Times, Serif">The Company may call the warrants for redemption, in whole and not in part, at a price of $<span id="xdx_905_ecustom--WarrantsRedemptionPricePerShare_iI_c20210630_zi5OWHWc8Md6"><ix:nonFraction name="aaciu:WarrantsRedemptionPricePerShare" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span> per warrant:<br />
  &#160;</span></td></tr>
    <tr style="vertical-align: top">
      <td style="padding-top: 2.4pt; padding-right: 8pt; padding-left: 15pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#8226;</span></td>
      <td style="padding-top: 2.4pt; padding-right: 2.4pt; padding-left: 2.4pt"><span style="font: 10pt Times New Roman, Times, Serif">at any time after the warrants become exercisable,<br />
  &#160;</span></td></tr>
    <tr style="vertical-align: top">
      <td style="padding-top: 2.4pt; padding-right: 8pt; padding-left: 15pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#8226;</span></td>
      <td style="padding-top: 2.4pt; padding-right: 2.4pt; padding-left: 2.4pt"><span style="font: 10pt Times New Roman, Times, Serif">upon not less than <span id="xdx_901_ecustom--NoticePeriodForWarrantsRedemption_dtD_c20201106__20210630_zeUMHMZmZaV3"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" format="ixt-sec:durday" name="aaciu:NoticePeriodForWarrantsRedemption">30</ix:nonNumeric></span> days&#8217; prior written notice of redemption to each warrant holder</span></td></tr>
    </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
    <tr style="vertical-align: top">
      <td style="width: 4%; padding-top: 2.4pt; padding-right: 8pt; padding-left: 15pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#8226;</span></td>
      <td style="width: 96%; padding-top: 2.4pt; padding-right: 2.4pt; padding-left: 2.4pt"><span style="font: 10pt Times New Roman, Times, Serif">if, and only if, the reported last sale price of the common stock equals or exceeds $<span id="xdx_90F_ecustom--CommonStockSharePricePerShareForWarrantsRedemption_iI_c20210630_zHTxhyWgvcue"><ix:nonFraction name="aaciu:CommonStockSharePricePerShareForWarrantsRedemption" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18.00</ix:nonFraction></span> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations) for any <span id="xdx_905_ecustom--PeriodOfTradingDaysWithinSpecifiedWindowForMinimumCommonStockPriceForWarrantsRedemption_dtD_c20201106__20210630_zvjRIDU87Dx1"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" format="ixt-sec:durday" name="aaciu:PeriodOfTradingDaysWithinSpecifiedWindowForMinimumCommonStockPriceForWarrantsRedemption">20</ix:nonNumeric></span> trading days within a <span id="xdx_906_ecustom--TradingDaysSpecifiedWindowForMinimumCommonStockPriceForWarrantsRedemption_dtD_c20201106__20210630_zJvqadVu4Ox"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" format="ixt-sec:durday" name="aaciu:TradingDaysSpecifiedWindowForMinimumCommonStockPriceForWarrantsRedemption">30</ix:nonNumeric></span>-trading day period commencing at any time after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and<br />
  &#160;</span></td></tr>
    <tr style="vertical-align: top">
      <td style="padding-top: 2.4pt; padding-right: 8pt; padding-left: 15pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #252525">&#8226;</span></td>
      <td style="padding-top: 2.4pt; padding-right: 2.4pt; padding-left: 2.4pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants.</span></td></tr>
    </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  
  
  <ix:exclude><!-- Field: Page; Sequence: 17 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page --></ix:exclude>
  
  <ix:exclude><p id="xdx_233_zOgyoxvfW1Hl" style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&#160;</p></ix:exclude>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If the Company calls the warrants
  for redemption as described above, the Company&#8217;s management will have the option to require all holders that wish to exercise warrants
  to do so on a &#8220;cashless basis.&#8221; In such event, each holder would pay the exercise price by surrendering the warrants for that
  number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying
  the warrants, multiplied by the difference between the exercise price of the warrants and the &#8220;fair market value&#8221; (defined
  below) by (y) the fair market value. The &#8220;fair market value&#8221; for this purpose shall mean the average reported last sale price
  of the shares of common stock for the <span id="xdx_90D_ecustom--PeriodOfTradingDaysToDetermineFairMarketValueOfCommonStock_dtD_c20201106__20210630_z4QLfG7Ew5Fj"><ix:nonNumeric contextRef="From2020-11-06to2021-06-30" format="ixt-sec:durday" name="aaciu:PeriodOfTradingDaysToDetermineFairMarketValueOfCommonStock">5</ix:nonNumeric></span> trading days ending on the third trading day prior to the date on which the notice of redemption
  is sent to the holders of warrants.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In addition, if (x) the Company
  issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of the
  initial Business Combination at an issue price or effective issue price of less than $<span id="xdx_902_ecustom--CommonStockIssuePricePerShareBelowWhichTriggersWarrantAdjustment_iI_c20210630_zbofxCGe1fJ8"><ix:nonFraction name="aaciu:CommonStockIssuePricePerShareBelowWhichTriggersWarrantAdjustment" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.20</ix:nonFraction></span> per share of common stock (with such issue
  price or effective issue price to be determined in good faith by the Company&#8217;s board of directors, and in the case of any such issuance
  to the Sponsor, initial stockholders or their affiliates, without taking into account any founders&#8217; shares held by them prior to
  such issuance), (y) the aggregate gross proceeds from such issuances represent more than <span id="xdx_90D_ecustom--PercentageOfAvailableEquityProceedsBelowSpecifiedPriceWhichTriggersWarrantAdjustment_iI_uPure_c20210630_zRTPh6q32o98"><ix:nonFraction name="aaciu:PercentageOfAvailableEquityProceedsBelowSpecifiedPriceWhichTriggersWarrantAdjustment" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60</ix:nonFraction>%</span> of the total equity proceeds, and interest
  thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination
  (net of redemptions), and (z) the Market Value is below $<span id="xdx_908_ecustom--CommonStockMarketValuePerShareBelowWhichTriggersWarrantAdjustment_iI_c20210630_zp9xjoUKyBKb"><ix:nonFraction name="aaciu:CommonStockMarketValuePerShareBelowWhichTriggersWarrantAdjustment" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.20</ix:nonFraction></span> per share, the exercise price of the warrants will be adjusted (to the nearest
  cent) to be equal to <span id="xdx_901_ecustom--PercentageOfMarketValueForWarrantExercisePriceAdjustment_iI_uPure_c20210630_zX1YhnMHXde5"><ix:nonFraction name="aaciu:PercentageOfMarketValueForWarrantExercisePriceAdjustment" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">115</ix:nonFraction>%</span> of the greater of (i) the Market Value or (ii) the price at which the Company issues the additional shares of
  common stock or equity-linked securities.</p>
  
  </ix:nonNumeric><p id="xdx_811_z8KkInONTced" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt; color: #252525">&#160;</p>
  
  <ix:nonNumeric contextRef="From2020-11-06to2021-06-30" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_zmY7aefCt2Ob" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525"><b>Note 8 &#8212; <span id="xdx_827_zjhdcBKYU0d5">Subsequent Events</span></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #252525">&#160;</p>
  
  <p style="font: 10pt/10.7pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-indent: 0.5in">The Company evaluated subsequent events
  and transactions that occurred after the balance sheet date up to the date that the financial statements were available to be issued.
  The Company did not identify any subsequent events other than noted below that would have required adjustment or disclosure in these unaudited
  condensed financial statements.</p>
  
  <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-indent: 0.5in">On July 23, 2021, the Sponsor purchased
  an additional <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210722__20210723__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zk5rj66Cddj7" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-07-222021-07-23_us-gaap_SubsequentEventMember_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,200,000</ix:nonFraction></span> Founder Shares at a purchase price of $<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_c20210723__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zFMTkK2uL1Ie" title="Price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-07-23_us-gaap_SubsequentEventMember_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.006</ix:nonFraction></span> per share, resulting in the Sponsor holding an aggregate of <span id="xdx_907_eus-gaap--CommonStockSharesOutstanding_iI_c20210723__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z0H6WYYVjp11" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-07-23_us-gaap_SubsequentEventMember_custom_FounderSharesMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,007,500</ix:nonFraction></span>
  shares of common stock and the Chief Executive Officer, President and independent directors holding an aggregate of <span id="xdx_907_eus-gaap--CommonStockSharesOutstanding_iI_c20210723__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChiefExecutiveOfficerPresidentAndIndependentDirectorsMember_zkhOEgkR4eT6"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-07-23_us-gaap_SubsequentEventMember_custom_FounderSharesMember_custom_ChiefExecutiveOfficerPresidentAndIndependentDirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">205,000</ix:nonFraction></span> shares of
  common stock. At July 23, 2021, the Founder Shares include an aggregate of up to <span id="xdx_900_eus-gaap--CommonStockOtherSharesOutstanding_iI_c20210723__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_z63dFOZOLzi4" title="Shares subject to forfeiture"><ix:nonFraction name="us-gaap:CommonStockOtherSharesOutstanding" contextRef="AsOf2021-07-23_us-gaap_SubsequentEventMember_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,125,000</ix:nonFraction></span> shares subject to forfeiture by the Sponsor
  to the extent that the underwriters&#8217; over-allotment option is not exercised in full or in part.</p>
  
  <p style="font: 10pt/10.7pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-indent: 0.5in">On August 17, 2021, the Company commenced
  the IPO of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zHVpIco4iAK8"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_us-gaap_IPOMember_custom_UnitsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,000,000</ix:nonFraction></span> units at $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_z1D8UQ5MoVE2"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember_us-gaap_IPOMember_custom_UnitsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Unit. Simultaneously with the consummation of the IPO, the Company consummated the private placement
  of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementClassOfStockAxis__custom--PrivateSharesMember_zizDfawtvPJi"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_PrivateSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">459,500</ix:nonFraction></span> Private Shares, at a price of $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_c20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementClassOfStockAxis__custom--PrivateSharesMember_zbz8CfjLO106"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-08-17_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_PrivateSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per share for an aggregate purchase price of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20210816__20210817__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementClassOfStockAxis__custom--PrivateSharesMember_zi8etpvwuFp5" title="Aggregate purchase price"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-08-162021-08-17_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_PrivateSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,595,000</ix:nonFraction></span>.</p>
  
  <p style="font: 10pt/10.7pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-indent: 0.5in">After the close of the IPO, paying offering
  costs and having excess funds released from the trust account, on August 18, 2021, the Company had $<span id="xdx_90B_eus-gaap--Cash_iI_c20210818__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zEtNR6C4ifsi" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2021-08-18_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,163,587</ix:nonFraction></span> in cash available for working
  capital purposes.</p>
  
  </ix:nonNumeric><p id="xdx_81F_zchHLoENsnA4" style="font: 10pt/10.7pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-indent: 0.5in">&#160;</p>
  
  
  <!-- Field: Page; Sequence: 18 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><b>&#160;</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_008"></span>Item 2. Management&#8217;s Discussion and Analysis
  of Financial Condition and Results of Operations.</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; background-color: white">References
  to &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221; are to Armada Acquisition Corp. I, except where
  the context requires otherwise. The following discussion should be read in conjunction with our unaudited condensed financial statements
  and related notes thereto included elsewhere in this report.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white"><b>Cautionary Note
  Regarding Forward-Looking Statements</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; background-color: white"><i>This
  Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
  amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). We have based these forward-looking
  statements on our current expectations and projections about future events. These forward-looking statements are subject to known and
  unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements
  to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking
  statements. In some cases, you can identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;should,&#8221;
  &#8220;could,&#8221; &#8220;would,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221;
  &#8220;continue,&#8221; or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy
  include, but are not limited to, those described in our other Securities and Exchange Commission (&#8220;SEC&#8221;) filings.</i></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white"><b>Overview</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; background-color: white">We
  are a blank check company incorporated in Delaware on November 5, 2020, for the purpose of effecting a merger, stock exchange, asset acquisition,
  stock purchase, reorganization or other similar business combination with one or more businesses.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; background-color: white">On
  August 17, 2021, we consummated our IPO of 15,000,000 units, at $10.00 per unit, generating gross proceeds of $150 million.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; background-color: white">Simultaneously
  with the closing of the IPO, we consummated the private placement of 459,500 Private Shares for an aggregate purchase price of $4,595,000.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; background-color: white">Upon
  the closing of the IPO on August 17, 2021, $150,000,000 ($10.00 per unit) from the net proceeds of the sale of the units in the IPO and
  the sale of Private Shares were placed in the Trust Account.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-right: 0; margin-left: 0; background-color: white">If
  we are unable to complete the initial Business Combination within the Combination Period, we will (i) cease all operations except for
  the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the
  outstanding public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account,
  including interest earned on the funds held in the Trust Account and not previously released to us but net of taxes payable ( and less
  up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will
  completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions,
  if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of
  our remaining stockholders and our board of directors, liquidate and dissolve, subject (in the case of (ii) and (iii) above) to our obligations
  under Delaware law to provide for claims of creditors and the requirements of other applicable law.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">We cannot
  assure you that our plans to complete our initial business combination will be successful.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white"><b>Results of Operations</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; background-color: white">Our
  entire activity since inception up to June 30, 2021 was our formation and preparation for our IPO. We will not generate any operating
  revenues until the closing and completion of our initial business combination, at the earliest.</p>
  
  
  <!-- Field: Page; Sequence: 19 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; background-color: white">For
  the three months ended June 30, 2021, we had net loss of $1,969, which consisted of formation and operating costs of $1,969.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; background-color: white">For
  the period from November 5, 2020 through June 30, 2021, we had net loss of $4,408, which consisted of formation and operating costs of
  $4,408.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white"><b><i>Liquidity and
  Capital Resources</i></b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-right: 0; margin-left: 0; background-color: white">As
  of June 30, 2021, we had approximately $13,746 in our operating account and working capital deficit of $143,623 (excluding deferred offering
  costs).</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-right: 0; margin-left: 0; background-color: white">Our
  liquidity needs up to June 30, 2021 had been satisfied through advances from related parties to cover certain offering costs and formation
  expenses of $132,352 (see Note 5). In order to finance transaction costs in connection with a Business Combination, the Sponsor or an
  affiliate of the Sponsor or certain of our officers and directors may, but are not obligated to, provide us with Working Capital Loans,
  as defined below (see Note 5). As of June 30, 2021, there were no amounts outstanding under any Working Capital Loans.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-right: 0; margin-left: 0; background-color: white">Subsequent
  to the period covered by this quarterly report on Form 10-Q (the &#8220;Quarterly Report&#8221;), we consummated our IPO (see Note 3)
  and the sales of Private Shares (See Note 4). Of the net proceeds from the IPO and the sales of Private Shares, $150,000,000 of cash was
  placed in the Trust Account and $1,605 of cash was held outside of the Trust Account and is available for the Company&#8217;s working
  capital purposes. After the closing of the IPO, paying offering costs and having excess funds released from the trust account, on August
  18, 2021, the Company had $1,163,587 in cash available for working capital purposes.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-right: 0; margin-left: 0">Based on
  the foregoing, management believes that we will have sufficient working capital and borrowing capacity to meet our needs through the earlier
  of the consummation of a Business Combination or one year from this filing. Over this time period, we will be using these funds for paying
  existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on
  prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring,
  negotiating and consummating the Business Combination.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white"><b>Critical Accounting
  Policies</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; background-color: white">The
  preparation of these unaudited condensed financial statements in conformity with US GAAP requires management to make estimates and assumptions
  that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited
  condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those
  estimates. We have identified the following as our critical accounting policies:</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white"><b>Deferred Offering
  Costs</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in; background-color: white">Deferred
  offering costs consisted of legal and accounting expenses incurred through the balance sheet date that were directly related to the IPO
  and that were charged to stockholders&#8217; equity upon the completion of the IPO on August 17, 2021.</p>
  
  
  <!-- Field: Page; Sequence: 20 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><b>&#160;</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in; background-color: white"><b>Recent Accounting
  Pronouncements</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">In August
  2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, Debt
  &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity
  (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current
  models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative
  scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces
  additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity.
  ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible
  instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption
  permitted beginning on January 1, 2021. We are currently assessing the impact, if any, that ASU 2020-06 would have on its financial position,
  results of operations or cash flows.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Management
  does not believe that any recently issued, but not effective, accounting pronouncements, if currently adopted, would have a material effect
  on our unaudited condensed financial statements.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0; background-color: white"><b>Off-Balance&#160;Sheet Arrangements;
  Commitments and Contractual Obligations</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in; background-color: white"><b>&#160;</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in; background-color: white"><b>Registration
  Rights</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The holders
  of the Founder Shares issued and outstanding on the date of the IPO, as well as the holders of the representative shares, Private Shares
  and any shares the sponsor, officers, directors or their affiliates may issue in payment of Working Capital Loans made to us, will be
  entitled to registration rights pursuant to an agreement to be signed prior to or on the effective date of the IPO. The holders of a majority
  of these securities (other than the holders of the representative shares) are entitled to make up to two demands that we register such
  securities. The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three
  months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority of the Private
  Shares and shares issued to the Sponsor, officers, directors or their affiliates in payment of Working Capital Loans made to us can elect
  to exercise these registration rights at any time after we consummate a business combination. In addition, the holders have certain &#8220;piggy-back&#8221;
  registration rights with respect to registration statements filed subsequent to the consummation of a business combination. We will bear
  the expenses incurred in connection with the filing of any such registration statements.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><b>Underwriting Agreement</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">We granted
  the underwriters a 45-day option from the date of the IPO to purchase up to an additional 2,250,000 units to cover over-allotments, if
  any.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The underwriters
  were paid a cash underwriting discount of 1.0% of the gross proceeds of the IPO, or $1,500,000 (and are entitled to an additional $225,000
  of deferred underwriting commission payable at the time of an initial Business Combination if the underwriters&#8217; over-allotment is
  exercised in full).</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_009"></span>Item 3. Quantitative and Qualitative Disclosures
  About Market Risk</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Not required for smaller reporting
  companies.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_010"></span>Item 4. Controls and Procedures</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Evaluation of Disclosure Controls and Procedures</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Disclosure controls and procedures
  are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized,
  and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated
  to our management, including our principal executive officer and principal financial officer or persons performing similar functions,
  as appropriate to allow timely decisions regarding required disclosure.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>
  
  <!-- Field: Page; Sequence: 21 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Under the supervision and with
  the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted
  an evaluation of the effectiveness of our disclosure controls and procedures as of June 30, 2021, as such term is defined in Rules 13a-15(e)
  and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial and accounting
  officer have concluded that as of June 30, 2021, our disclosure controls and procedures were effective.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Changes in Internal Control over Financial Reporting</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the most recently completed
  fiscal quarter ended June 30, 2021, there was no change in our internal control over financial reporting that has materially affected,
  or is reasonably likely to materially affect, our internal control over financial reporting.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  
  <!-- Field: Page; Sequence: 22 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><b>&#160;</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="a_011"></span>PART II - OTHER INFORMATION</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_012"></span>Item 1. Legal Proceedings.</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">None.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_013"></span>Item 1A. Risk Factors.</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Not required
  for smaller reporting companies.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_014"></span>Item 2. Unregistered Sales of Equity Securities
  and Use of Proceeds.</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Use of Proceeds</i></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>&#160;</i></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On August 17, 2021, we consummated
  our IPO of 15,000,000 Units, each unit consisting of one share of common stock and one-half of one redeemable warrant of the Company,
  with each whole warrant entitling the holder thereof to purchase one share of common stock for $11.50 per share. The Units were sold at
  a price of $10.00 per unit, generating gross proceeds to the Company of $150,000,000. In connection with the IPO, the underwriters were
  granted a 45-day option from the date of the prospectus (the &#8220;Over-Allotment Option&#8221;) to purchase up to 2,250,000 additional
  units (the &#8220;Over-Allotment Units&#8221;) to cover over-allotments, if any. Northland acted as sole book-running manager of the IPO.
  The securities in the offering were registered under the Securities Act on a registration statement on Form S-1 (No. 333-257692), as amended.
  The SEC declared the registration statement effective on August 12, 2021.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Simultaneously with the consummation
  of the IPO, we consummated the private placement of an aggregate of 459,500 Private Shares at a price of $10.00 per share, generating
  gross proceeds of $4,595,000. The issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities
  Act.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Private Shares are identical
  to the shares sold in the IPO, except that the Private Shares are not transferable, assignable or salable until 30 days after the completion
  of our initial business combination, subject to certain limited exceptions.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We paid a total of $1,500,000
  in underwriting discounts and commissions and $1,842,968 for other offering costs related to the IPO. In addition, the underwriters agreed
  to defer up to $225,000 in underwriting discounts and commissions, in the event the underwriters&#8217; over-allotment option is exercised
  in full.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Of the net proceeds from the IPO
  and the sales of the Private Shares, $150,000,000 of cash was placed in the Trust Account and $1,605 of cash was held outside of the Trust
  Account and is available for the Company&#8217;s working capital purposes. After the closing of the IPO, paying offering costs and having
  excess funds released from the trust account, on August 18, 2021, the Company had $1,163,587 in cash available for working capital purposes.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">There
  has been no material change in the planned use of the proceeds from the IPO and sales of the Private Shares as is described in the Company&#8217;s
  final prospectus related to the IPO.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="a_015"></span><b>Item 3. Defaults Upon Senior Securities.</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">None.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_016"></span>Item 4. Mine Safety Disclosures.</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Not Applicable.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_017"></span>Item 5. Other Information.</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">None.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  
  <!-- Field: Page; Sequence: 23 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><b>&#160;</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><b><span id="a_018"></span>Item 6. Exhibits</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following exhibits are filed
  as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <tr style="vertical-align: bottom">
      <td style="border-bottom: black 1.5pt solid; width: 9%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>No.</b></span></td>
      <td style="width: 1%">&#160;</td>
      <td style="border-bottom: black 1.5pt solid; width: 90%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Description of Exhibit</b></span></td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">1.1</span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1844817/000095015921000262/ex1-1.htm" style="-sec-extract: exhibit">Underwriting Agreement, dated August 12, 2021, by and between the Company and Northland, as representative of the several underwriters. <sup>(1)</sup></a></span></td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">3.1</span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1844817/000095015921000262/ex3-1.htm" style="-sec-extract: exhibit">Second Amended and Restated Certificate of Incorporation. <sup>(1)</sup></a></span></td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">3.2</span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; color: #000000"><a href="http://www.sec.gov/Archives/edgar/data/1844817/000095015921000185/ex3-3.htm" style="-sec-extract: exhibit">Bylaws.<sup>(2)</sup></a></span></td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">4.1 </span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1844817/000095015921000262/ex4-1.htm" style="-sec-extract: exhibit">Warrant Agreement, dated August 12, 2021, by and between the Company and Continental Stock Transfer &amp; Trust Company (&#8220;CST&#8221;), as warrant agent. <sup>(1)</sup></a></span></td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">10.1</span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1844817/000095015921000262/ex10-2.htm" style="-sec-extract: exhibit">Investment Management Trust Agreement, dated August 12, 2021, by and between the Company and CST, as trustee. <sup>(1)</sup></a></span></td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">10.2</span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1844817/000095015921000262/ex10-3.htm" style="-sec-extract: exhibit">Registration Rights Agreement, dated August 12, 2021, by and between the Company, its officers, its directors, Armada Sponsor LLC (the &#8220;Sponsor&#8221;) and EarlyBirdCapital, Inc. <sup>(1)</sup></a></span></td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">10.3</span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1844817/000095015921000262/ex10-5.htm" style="-sec-extract: exhibit">Private Placement Shares Purchase Agreement, dated August 12, 2021, by and between the Company and the Sponsor. <sup>(1)</sup></a></span></td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">10.4</span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1844817/000095015921000262/ex10-1.htm" style="-sec-extract: exhibit">Letter Agreement, dated August 12, 2021, by and among the Company, its officers, its directors, and the Sponsor. <sup>(1)</sup></a></span></td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">10.5</span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1844817/000095015921000262/ex10-4.htm" style="-sec-extract: exhibit">Administrative Services Agreement, dated August 12, 2021, by and between the Company and the Sponsor. <sup>(1)</sup></a></span></td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">10.6</span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1844817/000095015921000262/ex10-6.htm" style="-sec-extract: exhibit">Stock Escrow Agreement, dated August 12, 2021, by and between the Company, its directors, its officers, the Sponsor and CST. <sup>(1)</sup></a></span></td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center">10.7</td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1844817/000095015921000262/ex10-7.htm" style="-sec-extract: exhibit">Business Combination Marketing Agreement, dated August 12, 2021, by and between the Company
      and Northland. <sup>(1)</sup></a></td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">31.1*</span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex31-1.htm">Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">31.2*</span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex31-2.htm">Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">32.1**</span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex32-1.htm">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">32.2**</span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex32-2.htm">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">101.INS*</span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">XBRL Instance Document</span></td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">101.CAL*</span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">101.SCH*</span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Schema Document</span></td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">101.DEF*</span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">101.LAB*</span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Labels Linkbase Document</span></td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">101.PRE*</span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">104*</span></td>
      <td style="text-align: justify">&#160;</td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).</span></td></tr>
    </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 3pt">&#160;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <tr style="vertical-align: top">
      <td style="width: 34px; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">*</span></td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Filed herewith.</span></td></tr>
    <tr style="vertical-align: top">
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">**</span></td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Furnished herewith.</span></td></tr>
    </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <tr style="vertical-align: top">
      <td style="width: 34px; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(1)</span></td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Previously filed as an exhibit to our Current Report on Form 8-K filed on August 18, 2021 and incorporated by reference herein.</span></td></tr>
    <tr style="vertical-align: top">
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(2)</span></td>
      <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Previously filed as an exhibit to our Registration Statement on Form S-1 on July 2, 2021 and incorporated by reference herein.</span></td></tr>
    </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  
  <!-- Field: Page; Sequence: 24 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</td></tr></table></div>
      <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: left; width: 100%"><a href="#TOC">Table of Contents</a></td></tr></table></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><b>&#160;</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="a_019"></span><b>SIGNATURES</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In accordance with the requirements
  of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <tr style="vertical-align: top">
      <td>&#160;</td>
      <td colspan="2"><span style="font: 10pt Times New Roman, Times, Serif"><b>ARMADA ACQUISITION CORP. I</b></span></td></tr>
    <tr style="vertical-align: top">
      <td style="width: 60%">&#160;</td>
      <td style="width: 5%">&#160;</td>
      <td style="width: 35%">&#160;</td></tr>
    <tr>
      <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">Date: September 27, 2021</span></td>
      <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">By:</span></td>
      <td style="border-bottom: black 1.5pt solid; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif">/s/ Stephen P. Herbert</span></td></tr>
    <tr>
      <td style="vertical-align: top">&#160;</td>
      <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">Name:&#160;</span></td>
      <td style="vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif">Stephen P. Herbert</span></td></tr>
    <tr>
      <td style="vertical-align: top">&#160;</td>
      <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">Title:</span></td>
      <td style="vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif">Chief Executive Officer</span></td></tr>
    <tr style="vertical-align: top">
      <td>&#160;</td>
      <td>&#160;</td>
      <td><span style="font: 10pt Times New Roman, Times, Serif">(Principal Executive Officer)</span></td></tr>
    <tr style="vertical-align: top">
      <td>&#160;</td>
      <td>&#160;</td>
      <td>&#160;</td></tr>
    <tr>
      <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">Date: September 27, 2021</span></td>
      <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">By:</span></td>
      <td style="border-bottom: black 1.5pt solid; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif">/s/ Douglas M. Lurio</span></td></tr>
    <tr>
      <td style="vertical-align: top">&#160;</td>
      <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">Name:</span></td>
      <td style="vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif">Douglas M. Lurio</span></td></tr>
    <tr style="vertical-align: top">
      <td>&#160;</td>
      <td><span style="font: 10pt Times New Roman, Times, Serif">Title:</span></td>
      <td><span style="font: 10pt Times New Roman, Times, Serif">President</span></td></tr>
    <tr style="vertical-align: top">
      <td>&#160;</td>
      <td>&#160;</td>
      <td><span style="font: 10pt Times New Roman, Times, Serif">(Principal Accounting and Financial Officer)</span></td></tr>
    </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">&#160;</p>
  
  
  <!-- Field: Page; Sequence: 25; Options: NewSection Last; Value: 1 -->
      <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font-size: 10pt; text-align: center; width: 100%">&#160;</td></tr></table></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><b>&#160;</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"></p>
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  </body>
  </html>
metadata_documents: [{"type": "10-Q", "sequence": "1", "filename": "aaciu10q.htm", "description": "ARMADA ACQUISITION CORP. I FORM 10-Q", "secsgml_size_bytes": 354363}]
metadata_filer: {"company-data": {"conformed-name": "Armada Acquisition Corp. I", "cik": "0001844817", "assigned-sic": "6770", "irs-number": "853810850", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "10-Q", "act": "34", "file-number": "001-40742", "film-number": "211281733"}, "business-address": {"street1": "2005 MARKET STREET, SUITE 3120", "city": "PHILADELPHIA", "state": "PA", "zip": "19103", "phone": "2676791808"}, "mail-address": {"street1": "2005 MARKET STREET, SUITE 3120", "city": "PHILADELPHIA", "state": "PA", "zip": "19103"}}
text: UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM
  10-Q
  (Mark One)
  ☒
  QUARTERLY REPORT PURSUANT TO SECTION 13
  OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
  For the quarterly period ended
  June 30, 2021
  ☐
  TRANSITION REPORT PURSUANT TO SECTION 13
  OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
  For the transition period from               to
  Commission File No.
  001-40742
  Armada Acquisition Corp. I
  (Exact name of registrant as specified in its charter)
  Delaware
  85-3810850
  (State or other jurisdiction of
  incorporation or organization)
  (I.R.S. Employer
  Identification No.)
  2005 Market Street
  ,
  Suite 3120
  Philadelphia
  ,
  PA
  1910
  (Address of Principal Executive Offices, including zip code)
  (215)
  543-6886
  (Registrant's telephone number, including area code)
  N/A
  (Former name, former address and former fiscal year, if changed since last report)
  Securities registered pursuant
  to Section 12(b) of the Act:
  Title of each class
  Trading Symbol(s)
  Name of each exchange on which registered
  Units, each consisting of one share of Common Stock and one-half of one Redeemable Warrant
  AACIU
  The Nasdaq Stock Market LLC
  Common Stock, par value $0.0001 per share
  AACI
  The Nasdaq Stock Market LLC
  Warrants, each exercisable for one share of Common Stock for $11.50 per share
  AACIW
  The Nasdaq Stock Market LLC
  Indicate by check mark whether
  the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
  preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
  filing requirements for the past 90 days. Yes ☐
  No
  ☒
  Table of Contents
  Indicate by check mark whether
  the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T
  (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit
  such files).
  Yes
  ☒   No ☐
  Indicate by check mark whether
  the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging
  growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting
  company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
  ☐ Large accelerated filer
  ☐ Accelerated filer
  ☒
  Non-accelerated filer
  ☒
  Smaller reporting company
  ☒
  Emerging growth company
  If an emerging growth company,
  indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
  accounting standards provided pursuant to Section 13(a) of the Exchange Act.
  ☐
  Indicate by check mark whether
  the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act):
  Yes
  ☒   No ☐
  As of September 27, 2021, there
  were
  21,834,500
  shares of common stock issued and outstanding.
  Table of Contents
  ARMADA ACQUISITION CORP. I
  Quarterly Report on Form 10-Q
  Table
  of Contents
  PART I. FINANCIAL INFORMATION
  Item 1.
  Financial Statements
  1
  Unaudited Condensed Balance Sheet as of June 30, 2021
  1
  Unaudited Condensed Statements of Operations for the Three Months ended June 30, 2021 and for the period from November 5, 2020 (Inception) through June 30, 2021
  2
  Unaudited Condensed Statement of Changes in Stockholders' Equity for the period from November 5, 2020 (Inception) through June 30, 2021
  3
  Unaudited Condensed Statement of Cash Flows for the period from November 5, 2020 (Inception) through June 30, 2021
  4
  Notes to Unaudited Condensed Financial Statements
  5
  Item 2.
  Management's Discussion and Analysis of Financial Condition and Results of Operations
  16
  Item 3.
  Quantitative and Qualitative Disclosures About Market Risk
  18
  Item 4.
  Controls and Procedures
  18
  PART II. OTHER INFORMATION
  Item 1.
  Legal Proceedings
  20
  Item 1A.
  Risk Factors
  20
  Item 2.
  Unregistered Sales of Equity Securities and Use of Proceeds
  20
  Item 3.
  Defaults Upon Senior Securities
  20
  Item 4.
  Mine Safety Disclosures
  20
  Item 5.
  Other Information
  20
  Item 6.
  Exhibits
  21
  SIGNATURES
  22
  i
  Table of Contents
  PART I
  - FINANCIAL INFORMATION
  Item 1.
  Financial Statements.
  Armada
  Acquisition Corp. I
  UNAUDITED CONDENSED BALANCE SHEET
  JUNE 30, 2021
  Assets
  Cash
  $
  13,746
  Due from Sponsor
  29,070
  Prepaid expenses
  8,171
  Deferred offering costs
  168,285
  Total Assets
  $
  219,272
  Liabilities and Stockholders' Equity
  Current liabilities:
  Accrued offering costs and expenses
  $
  62,258
  Advances from related parties
  132,352
  Total current liabilities
  194,610
  Commitments and Contingencies (Note 6)
  Stockholders' Equity:
  Preferred stock, $
  0.0001
  par value;
  1,000,000
  shares authorized;
  none
  issued and outstanding
  —
  Common stock, $
  0.0001
  par value;
  100,000,000
  shares authorized;
  5,175,000
  shares issued and outstanding
  (1)
  517
  Additional paid-in capital
  28,553
  Accumulated deficit
  (
  4,408
  )
  Total stockholders' equity
  24,662
  Total Liabilities and Stockholders' Equity
  $
  219,272
  (1)
  Includes up to
  675,000
  shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters
  (see Note 5).
  The accompanying notes
  are an integral part of these unaudited condensed financial statements.
  1
  Table of Contents
  Armada
  Acquisition Corp. I
  UNAUDITED CONDENSED STATEMENTS
  OF OPERATIONS
  For the Three Months Ended June 30, 2021
  For the period from November 5, 2020 (Inception) through June 30, 2021
  Formation cost
  $
  1,969
  $
  4,408
  Net loss
  $
  (
  1,969
  )
  $
  (
  4,408
  )
  Basic and diluted weighted average shares outstanding
  (1)
  4,500,000
  4,500,000
  Basic and diluted net loss per share
  $
  (
  0.00
  )
  $
  (
  0.00
  )
  (1)
  Excludes
  675,000
  shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters
  (see Note 5).
  The accompanying notes are
  an integral part of these unaudited condensed financial statements.
  2
  Table of Contents
  Armada Acquisition Corp. I
  UNAUDITED CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS'
  EQUITY
  FOR THE PERIOD FROM NOVEMBER 5, 2020 (INCEPTION) THROUGH JUNE 30, 2021
  Common Stock
  Additional
  Accumulated
  Total Stockholders'
  Shares
  (1)
  Amount
  Paid-in Capital
  Deficit
  Equity
  Balance as of November 5, 2020 (inception)
  —
  $
  —
  $
  —
  $
  —
  $
  —
  Common Stock issued to Sponsor
  4,312,500
  431
  24,569
  —
  25,000
  Issuance of Representative shares
  250,000
  25
  (
  25
  )
  —
  —
  Net loss
  —
  —
  —
  (
  2,439
  )
  (
  2,439
  )
  Balance as of March 31, 2021
  4,562,500
  $
  456
  $
  24,544
  $
  (
  2,439
  )
  $
  22,561
  87,500
  of Representative shares returned to the Company
  (
  87,500
  )
  (
  9
  )
  9
  —
  —
  Additional
  700,000
  shares of Common Stock issued to Sponsor
  700,000
  70
  4,000
  —
  4,070
  Net loss
  —
  —
  —
  (
  1,969
  )
  (
  1,969
  )
  Balance as of June 30, 2021
  5,175,000
  $
  517
  $
  28,553
  $
  (
  4,408
  )
  $
  24,662
  (1)
  Includes up to
  675,000
  shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters
  (see Note 5).
  The accompanying notes are
  an integral part of these unaudited condensed financial statements.
  3
  Table of Contents
  Armada
  Acquisition Corp. I
  UNAUDITED CONDENSED STATEMENT OF CASH FLOWS
  FOR THE PERIOD FROM NOVEMBER 5, 2020 (INCEPTION) THROUGH JUNE 30, 2021
  Cash Flows from Operating Activities:
  Net loss
  $
  (
  4,408
  )
  Adjustments to reconcile net loss to net cash used in operating activities:
  Amortization of prepaid expenses
  2,629
  Changes in current assets and liabilities:
  Accrued expenses
  5,400
  Prepaid assets
  (
  10,800
  )
  Net cash used in operating activities
  (
  7,179
  )
  Cash Flows from Financing Activities:
  Advances from related parties
  132,352
  Payment of deferred offering costs
  (
  111,427
  )
  Net cash provided by financing activities
  20,925
  Net change in cash
  13,746
  Cash, November 5, 2020 (inception)
  —
  Cash, end of the period
  $
  13,746
  Supplemental disclosure of noncash investing and financing activities
  Due from Sponsor from sale of common stock to initial stockholders
  $
  4,070
  Deferred offering costs paid by Sponsor in exchange for common stock
  $
  25,000
  Accrued deferred offering costs
  $
  56,858
  The accompanying notes are
  an integral part of these unaudited condensed financial statements.
  4
  Table of Contents
  Armada Acquisition Corp. I
  NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENT
  Note 1 —
  Organization, Business
  Operation and Going Concern
  Organization and General
  Armada Acquisition Corp. I (the
  "Company") is a newly organized blank check company incorporated as a Delaware corporation on
  November 5, 2020
  . The Company
  was incorporated for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or other similar
  business combination with one or more businesses (the "Business Combination"). The Company is in the process of searching
  for a Business Combination target but has not yet selected any specific Business Combination target. The Company intends to concentrate
  its efforts identifying businesses in the financial services industry with particular emphasis on businesses that are providing or changing
  technology for traditional financial services.
  As of June 30, 2021, the Company
  had not commenced any operations. All activity for the period from November 5, 2020 (inception) through June 30, 2021 relates to the Company's
  formation and preparation for the initial public offering (the "IPO"). The Company will not generate any operating revenues
  until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the
  form of interest income on cash and cash equivalents from the proceeds derived from the IPO.
  The Company has selected September
  30 as its fiscal year end.
  The Company's sponsor is
  Armada Sponsor LLC (the "Sponsor").
  Financing
  The registration statement for
  the Company's IPO was declared effective on August 12, 2021 (the "Effective Date"). On August 17, 2021, the Company
  consummated the IPO of
  15,000,000
  units at $
  10.00
  per unit (the "Units"), which is discussed in Note 3.
  Simultaneously with the consummation
  of the IPO, the Company consummated the private placement of
  459,500
  shares of common stock (the "Private Shares"), at a price
  of $
  10.00
  per share for an aggregate purchase price of $
  4,595,000
  .
  At August 17, 2021 related to the IPO, transaction costs amounted to $
  3,342,968
  consisting of $
  1,500,000
  of underwriting commissions, and $
  1,842,968
  of other offering costs. In addition, $
  1,605
  of cash was held outside of the Trust Account (as defined below) and is available for working capital purposes. After the close of the IPO, paying offering costs and having excess funds released from the trust account, on August 18, 2021, the Company had $
  1,163,587
  in cash available for working capital purposes.
  Trust Account
  Following the closing of the IPO
  on August 17, 2021 after releasing funds to the Company to be held outside of the Trust, $
  150,000,000
  ($
  10.00
  per Unit) from the net proceeds
  of the sale of the Units in the IPO was held in a trust account (the "Trust Account") and was invested only in U.S. government
  securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the "Investment
  Company Act"), having a maturity of
  185
  days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated
  under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned
  on the funds held in the Trust Account that may be released to the Company to pay income tax obligations, the proceeds from the IPO and
  the sale of the Private Shares will not be released from the Trust Account until the earlier of the completion of a Business Combination
  or the Company's redemption of
  100
  %
  of the outstanding public shares if it has not completed a Business Combination in the required
  time period The proceeds held in the Trust Account may be used as consideration to pay the sellers of a target business with which the
  Company completes a Business Combination. Any amounts not paid as consideration to the sellers of the target business may be used to finance
  operations of the target business.
  5
  Table of Contents
  The Company's management
  has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Shares, although
  substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.
  Initial Business
  Combination
  The Company must complete one
  or more initial Business Combinations having an aggregate fair market value of at least
  80
  %
  of the value of the assets held in the Trust
  Account (excluding taxes payable) at the time of the agreement to enter into the initial Business Combination. However, the Company will
  only complete a Business Combination if the post-transaction company owns or acquires
  50
  %
  or more of the outstanding voting securities
  of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment
  company under the Investment Company Act. There is no assurance that the Company will be able to complete a Business Combination successfully.
  In connection with any proposed
  Business Combination, the Company will either (1) seek stockholders' approval of the initial Business Combination at a meeting called
  for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against the proposed Business
  Combination or do not vote at all, into their pro rata share of the aggregate amount then on deposit in the Trust Account (net of taxes
  payable), or (2) provide its stockholders with the opportunity to sell their shares to the Company by means of a tender offer (and thereby
  avoid the need for a stockholder vote) for an amount equal to their pro rata share of the aggregate amount then on deposit in the Trust
  Account (net of taxes payable), in each case subject to the limitations described herein. The decision as to whether the Company will
  seek stockholders' approval of a proposed Business Combination or will allow stockholders to sell their shares to the Company in
  a tender offer will be made by the Company, solely in its discretion.
  The shares of common stock subject
  to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance
  with Accounting Standards Codification ("ASC") Topic 480 "Distinguishing Liabilities from Equity." In such case,
  the Company will proceed with a Business Combination if the Company has net tangible assets of at least $
  5,000,001
  upon such consummation
  of a Business Combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted
  in favor of the Business Combination.
  The Company will have
  15
  months
  (or
  18
  months if extended) from the closing of the IPO to complete the initial Business Combination (the "Combination Period").
  However, if the Company is unable to complete the initial Business Combination within the Combination Period, the Company will (i) cease
  all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter,
  redeem
  100
  %
  of the outstanding public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in
  the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company but net
  of taxes payable (and less up to $
  100,000
  of interest to pay dissolution expenses), divided by the number of then outstanding public shares,
  which redemption will completely extinguish public stockholders' rights as stockholders (including the right to receive further
  liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption,
  subject to the approval of the Company's remaining stockholders and the Company's board of directors, liquidate and dissolve,
  subject (in the case of (ii) and (iii) above) to the Company's obligations under Delaware law to provide for claims of creditors
  and the requirements of other applicable law.
  The Sponsor, officers and directors
  have agreed (i) to vote any shares owned by them in favor of any proposed Business Combination, (ii) not to redeem any shares in connection
  with a stockholder vote to approve a proposed initial Business Combination or sell any shares to the Company in a tender offer in connection
  with a proposed initial Business Combination, (iii) that the Founder Shares (as defined below) will not participate in any liquidating
  distributions from the Company's Trust Account upon winding up if a Business Combination is not consummated.
  6
  Table of Contents
  The Sponsor has agreed that it
  will be liable to ensure that the proceeds in the Trust Account are not reduced below $
  10.00
  per share by the claims of target businesses
  or claims of vendors or other entities that are owed money by the Company for services rendered or contracted for or products sold to
  the Company. The agreement entered into by the Sponsor specifically provides for two exceptions to the indemnity it has given: it will
  have no liability (1) as to any claimed amounts owed to a target business or vendor or other entity who has executed an agreement with
  the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account, or (2)
  as to any claims for indemnification by the underwriters of the IPO against certain liabilities, including liabilities under the Securities
  Act. However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has it independently verified
  whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor's only assets are securities
  of the Company. Therefore, the Company believes it is unlikely that the Sponsor will be able to satisfy its indemnification obligations
  if it is required to do so.
  Liquidity and Capital Resources
  As of June 30, 2021, the Company
  had approximately $
  13,746
  in its operating account and working capital deficit of $
  24,662
  (which includes deferred offering costs of $
  168,285
  that will
  be paid with proceeds from the IPO).
  The Company's liquidity
  needs up to June 30, 2021 had been satisfied through advances from related parties to cover certain offering costs and formation expenses
  of $
  132,352
  (see Note 5). In order to finance transaction costs in connection with a Business Combination, the Company's Sponsor
  or an affiliate of the Sponsor or certain of the Company's officers and directors may, but are not obligated to, provide the Company
  with Working Capital Loans, as defined below (see Note 5). As of June 30, 2021, there were no amounts outstanding under any Working Capital
  Loans.
  Subsequent to the period
  covered by this quarterly report on Form 10-Q (the "Quarterly Report"), the Company consummated its IPO (see Note 3) and sales
  of the Private Shares (See Note 4). Of the net proceeds from the IPO and the sales of the Private Shares, $
  150,000,000
  of cash was placed
  in the Trust Account and $
  1,605
  of cash was held outside of the Trust Account and is available for the Company's working capital
  purposes. After the close of the IPO, paying offering costs and having excess funds released from the trust account, on August 18, 2021,
  the Company had $
  1,163,587
  in cash available for working capital purposes.
  Based on the foregoing, management
  believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation
  of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing
  accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective
  target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating
  and consummating the Business Combination.
  Risks and Uncertainties
  Management is continuing to evaluate
  the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a
  negative effect on the Company's financial position, results of its operations and/or search for a target company, the specific
  impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments
  that might result from the outcome of this uncertainty.
  7
  Table of Contents
  Note 2 —
  Significant Accounting
  Policies
  Basis of Presentation
  The accompanying unaudited condensed
  financial statements are presented in conformity with accounting principles generally accepted in the United States of America ("US
  GAAP") and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). Accordingly,
  they do not include all of the information and footnotes required by US GAAP. In the opinion of management, the unaudited condensed financial
  statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and
  results for the period presented. Operating results for the period from November 5, 2020 (inception) through June 30, 2021 are not necessarily
  indicative of the results that may be expected through September 30, 2021.
  The accompanying unaudited condensed
  financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8-K and
  the final prospectus filed by the Company with the SEC on August 24, 2021 and August 16, 2021, respectively.
  Emerging Growth Company Status
  The Company is an "emerging
  growth company," as defined in Section 2(a) of the Securities Act of 1933, as amended (the "Securities Act"), as modified
  by the Jumpstart the Business Startups Act of 2012 (the "JOBS Act"), and it may take advantage of certain exemptions from
  various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not
  limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure
  obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding
  a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
  Further, Section 102(b)(1) of
  the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
  private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
  of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS
  Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
  growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period,
  which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company,
  as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
  This may make comparison of the Company's financial statements with the financial statements of another public company which is
  neither an emerging growth company nor an emerging growth company or which has opted out of using the extended transition period difficult
  or impossible because of the potential differences in accounting standards used.
  Use of Estimates
  The preparation of financial statements
  in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
  and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during
  the reporting period. Actual results could differ from those estimates.
  Cash and Cash Equivalents
  The Company considers all short-term
  investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $
  13,746
  in cash and
  no
  cash equivalents as of June 30, 2021.
  8
  Table of Contents
  Deferred Offering Costs
  Deferred offering costs consist
  of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO and
  that have been charged to stockholders' equity upon the completion of the IPO.
  Allocation of Proceeds
  FASB ASC 470-20,
  Debt with Conversion and Other Options, addresses the allocation of proceeds from the issuance of convertible debt into its equity and
  debt components. The Company applies this guidance to allocate IPO proceeds from the Units between common stock and warrants, using the
  residual method by allocating IPO proceeds first to fair value of the warrants, if any, and then common stock. Any amount paid to investors
  represents a reduction in the proceeds to be allocated.
  Net Loss Per Share
  Net loss per share is computed
  by dividing net loss by the weighted average number of common stock outstanding during the period, excluding common stock subject to forfeiture
  by the Sponsor. Weighted average shares were reduced for the effect of an aggregate of
  675,000
  shares of common stock that are subject
  to forfeiture if the over-allotment option is not exercised by the underwriters (see Note 5). At June 30, 2021, the Company did not have
  any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the
  earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.
  Fair Value of Financial Instruments
  The fair value of the Company's
  assets and liabilities approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term
  nature.
  Income Taxes
  The Company accounts for income
  taxes under ASC 740 Income Taxes ("ASC 740"). ASC 740 requires the recognition of deferred tax assets and liabilities for
  both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future
  tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established
  when it is more likely than not that all or a portion of deferred tax assets will not be realized.
  ASC 740 also clarifies the accounting
  for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold and measurement
  process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those
  benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740
  also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.
  The Company recognizes accrued
  interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts
  accrued for interest and penalties as of June 30, 2021. The Company is currently not aware of any issues under review that could result
  in significant payments, accruals or material deviation from its position.
  The Company has identified the
  United States as its only "major" tax jurisdiction.
  The Company may be subject to
  potential examination by federal and state taxing authorities in the areas of income taxes since inception. These potential examinations
  may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal
  and state tax laws. The Company's management does not expect that the total amount of unrecognized tax benefits will materially
  change over the next twelve months.
  9
  Table of Contents
  The provision for income taxes
  was deemed to be immaterial for the period from November 5, 2020 (inception) through June 30, 2021.
  Recent Accounting Pronouncements
  In August 2020, the Financial
  Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-06, Debt — Debt with
  Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity's Own Equity (Subtopic 815-40)
  ("ASU 2020-06") to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require
  separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception
  guidance pertaining to equity classification of contracts in an entity's own equity. The new standard also introduces additional
  disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity's own equity. ASU 2020-06
  amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments.
  ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted
  beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position,
  results of operations or cash flows.
  Management does not believe that
  any recently issued, but not effective, accounting pronouncements, if currently adopted, would have a material effect on the Company's
  unaudited condensed financial statements.
  Stock Based Compensation
  On June 16, 2021, the
  Sponsor transferred
  50,000
  shares of common stock to each of its Chief Executive Officer and its President and
  35,000
  shares of common stock to each of its
  three
  independent directors. The aggregate fair value of these shares was $
  509,552
  at June 30, 2021. We recognize compensation expense related to these transfers according to ASC 718-10-25-20 when the performance
  condition associated with these awards is probable of achievement. Since the stock grants contain the performance condition of
  consummating a business combination, the Company believes the appropriate accounting treatment is to defer recognition of the
  compensation costs until the consummation of an initial business combination. At June 30, 2021,
  no
  compensation expense was recognized related to these shares.
  Note 3 —
  IPO
  On August 17, 2021, the Company
  consummated its IPO of
  15,000,000
  Units, at a price of $
  10.00
  per Unit.
  Each Unit consists of one share of common stock and one-half of
  one redeemable warrant
  . Each whole warrant entitles the holder to purchase one share of common stock at a price of $
  11.50
  per share, subject
  to adjustment. Only whole warrants are exercisable. No fractional warrants will be issued upon separation of the units and only whole
  warrants will trade.
  The warrants will become exercisable
  30
  days after the completion of the initial Business Combination, and will expire
  five years
  after the completion of the initial
  Business Combination or earlier upon redemption or liquidation (see Note 7).
  Following the closing of the IPO
  and settlement of funds on August 17, 2021,
  $
  150,000,000
  ($
  10.00
  per Unit) from the net proceeds of the sale of the Units in the IPO and
  the sales of Private Shares was placed in the Trust Account and will be invested only in U.S. government treasury obligations with a maturity
  of
  185
  days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest
  only in direct U.S. government treasury obligations.
  Note 4 —
  Private Placement
  Simultaneously with the closing
  of the IPO, the Sponsor purchased an aggregate of
  459,500
  Private Shares, at a price of $
  10.00
  per Private Share, for an aggregate purchase
  price of $
  4,595,000
  in a private placement. The proceeds from the sale of the Private Shares was added to the proceeds of the IPO and
  placed in the Trust Account. If the Company does not complete an initial Business Combination within the Combination Period, the proceeds
  from the sale of the Private Shares will be included in the liquidating distribution to the public stockholders and the Private Shares
  will be worthless.
  10
  Table of Contents
  Note 5 —
  Related Party Transactions
  Founder Shares
  On February 3, 2021, a
  related party to the Sponsor paid $
  25,000
  ,
  or approximately $
  0.006
  per share, to cover certain offering costs in consideration for
  4,312,500
  shares of common stock, par value $
  0.0001
  (the "Founder Shares"). On June 16, 2021, the Sponsor purchased an additional
  700,000
  Founder Shares at a purchase price of $
  0.006
  per share and transferred
  50,000
  Founder Shares to each of its Chief Executive Officer and its President and
  35,000
  Founder Shares to each of its
  three
  independent directors. We recognize compensation expense related to these transfers according to ASC 718-10-25-20 when the
  performance condition associated with these awards is probable of achievement. Since the stock grants contain the performance
  condition of consummating a business combination, the Company believes the appropriate accounting treatment is to defer recognition
  of the compensation costs until the consummation of an initial business combination. At June 30, 2021, the Founder Shares include an
  aggregate of up to
  675,000
  shares subject to forfeiture by the Sponsor to the extent that the underwriters' over-allotment option is not exercised in
  full or in part.
  The Sponsor, officers and directors
  have agreed not to transfer, assign or sell any Founder Shares held by them until the earliest of (A)
  180
  days after the completion of
  the initial Business Combination and (B) subsequent to the initial Business Combination, the date on which the Company completes a liquidation,
  merger, stock exchange, reorganization or other similar transaction that results in all of the public stockholders having the right to
  exchange their public shares for cash, securities or other property.
  Additionally, upon consummation
  of the IPO, the Sponsor sold membership interests in the Sponsor to
  10
  anchor investors that purchased
  9.9
  %
  of the units sold in the IPO.
  The Sponsor sold membership interests in the Sponsor reflecting an allocation of
  131,250
  Founder Shares to each anchor investor, or an
  aggregate of
  1,312,500
  Founder Shares to all
  10
  anchor investors, at a purchase price of approximately $
  0.006
  per share. The Company estimated
  the aggregate fair value of these Founder Shares attributable to each anchor investor to be $
  424,491
  , or $
  3.23
  per share. The Company
  has offset the excess of the fair value against the gross proceeds from these anchor investors as a reduction in its additional paid-in
  capital in accordance with Staff Accounting Bulletin Topic 5A.
  Representative's Common
  Stock
  On February 8, 2021, EarlyBirdCapital,
  Inc. ("EBC") and Northland Securities, Inc. ("Northland") purchased
  162,500
  and
  87,500
  shares of common stock
  ("representative shares"), respectively, at an average purchase price of approximately $
  0.0001
  per share, or an aggregate
  purchase price of $
  25.00
  . On May 29, 2021, Northland returned
  87,500
  shares of common stock to the Company, for no consideration, which
  shares were subsequently cancelled.
  The representative shares are
  identical to the public shares included in the Units that were sold in the IPO, except that the representative shares are subject to certain
  transfer restrictions, as described in more detail below.
  The holders of the representative
  shares have agreed not to transfer, assign or sell any such shares until
  30
  days after the completion of an initial Business Combination.
  In addition, the holders of the representative shares have agreed (i) to waive their redemption rights (or right to participate in
  any tender offer) with respect to such shares in connection with the completion of an initial Business Combination and (ii) to waive
  their rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete an initial
  Business Combination within the Combination Period.
  Promissory Note—Related
  Party
  On February 3, 2021, the Sponsor
  agreed to loan the Company up to $
  300,000
  to be used for a portion of the expenses of the IPO. These loans are non-interest bearing, unsecured
  and are due at the earlier of
  October 31, 2021
  or the closing of the IPO. As of June 30, 2021, the Company had $
  132,352
  of borrowings under
  the promissory note.
  Due from Sponsor
  As of June 30, 2021, the Company
  was due from the Sponsor $
  29,070
  for the purchase of the Founder Shares.
  11
  Table of Contents
  Working Capital Loans
  In order to meet the Company's
  working capital needs following the consummation of the IPO, the Sponsor, officers, directors or their affiliates may, but are not obligated
  to, loan the Company funds ("Working Capital Loans"), from time to time or at any time, in whatever amount they deem reasonable
  in their sole discretion. Each loan would be non-interest bearing and be evidenced by a promissory note. The notes would either be paid
  upon consummation of the initial Business Combination, without interest, or, at holder's discretion, up to $
  1,500,000
  of the notes
  may be converted into shares of common stock at a price of $
  10.00
  per share. The shares would be identical to the Private Shares. In the
  event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust
  Account to repay such loaned amounts, but no proceeds from the Trust Account would be used for such repayment.
  Administrative Service Fee
  Commencing on the Effective
  Date, the Company will pay the Sponsor $
  10,000
  per month for office space, utilities and secretarial support. Upon completion of the initial Business Combination or the
  Company's liquidation, the Company will cease paying these monthly fees.
  Note 6 —
  Commitments and
  Contingencies
  Registration Rights
  The holders of the Founder Shares
  issued and outstanding on the date of the IPO, as well as the holders of the representative shares, Private Shares and any shares the
  Company's Sponsor, officers, directors or their affiliates may issue in payment of Working Capital Loans made to the Company, will
  be entitled to registration rights pursuant to an agreement signed on the Effective Date. The holders of
  a majority of these securities (other than the holders of the representative shares) are entitled to make up to two demands that the Company
  registers such securities. The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time
  commencing three months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority
  of the Private Shares and shares issued to the Company's Sponsor, officers, directors or their affiliates in payment of Working
  Capital Loans made to the Company can elect to exercise these registration rights at any time after the Company consummates a Business
  Combination. In addition, the holders have certain "piggy-back" registration rights with respect to registration statements
  filed subsequent to the Company's consummation of a Business Combination. The Company will bear the expenses incurred in connection
  with the filing of any such registration statements.
  Underwriting Agreement
  The Company granted the underwriters
  a
  45
  -day option from the date of the IPO to purchase up to an additional
  2,250,000
  units to cover over-allotments, if any.
  The underwriters were paid a cash
  underwriting discount of
  1.0
  %
  of the gross proceeds of the IPO, or
  $
  1,500,000
  (and are entitled to an additional $
  225,000
  of deferred
  underwriting commission payable at the time of an initial Business Combination if the underwriters' over-allotment is exercised
  in full).
  12
  Table of Contents
  Financial Advisory Fee
  The Company has engaged Cohen
  & Company Capital Markets, a division of J.V.B. Financial Group, LLC ("CCM"), an affiliate of a member of the Sponsor,
  to provide consulting and advisory services in connection with the IPO, for which it will receive an advisory fee equal to one (
  1.0
  ) percent
  of the aggregate proceeds of the IPO, or $
  1,500,000
  (or up to $
  1,725,000
  if the underwriters' over-allotment is exercised in full),
  upon closing of the IPO. Affiliates of CCM have and manage investment vehicles with a passive investment in the Sponsor. On August 18,
  2021, the Company paid to CCM in aggregate of $
  1,500,000
  . CCM has agreed to defer the payment of the portion of the advisory fee attributable
  to over-allotment option until the consummation of the initial Business Combination. CCM is engaged to represent the Company's interests
  only. CCM is not participating in the IPO as defined in FINRA Rule 5110(j)(16); it is acting as an independent financial adviser as defined
  in FINRA Rule 5110(j)(9). As such, CCM is not acting as an underwriter in connection with the IPO, it will not identify or solicit potential
  investors in the IPO or otherwise be involved in the distribution of the IPO. The Company will also engage CCM as an advisor in connection
  with the initial Business Combination for which it will earn an advisory fee of
  2.25
  %
  of the gross proceeds of the IPO, or $
  3,375,000
  (or up to $
  3,881,250
  if the underwriters' over-allotment is exercised in full), payable at closing of the Business Combination.
  Business Combination
  Marketing Agreement
  The Company will engage the representative
  of the underwriter as an advisor in connection with the initial Business Combination to assist in holding meetings with the Company's
  stockholders to discuss the potential Business Combination and the target business's attributes, introduce the Company to potential
  investors that are interested in purchasing the Company's securities in connection with the initial Business Combination and assist
  the Company with press releases and public filings in connection with the Business Combination. The Company will pay the representative
  a cash fee for such services upon the consummation of the initial Business Combination in an amount equal to
  2.25
  %
  of the gross proceeds
  of the IPO, or $
  3,375,000
  (or up to $
  3,881,250
  if the underwriters' over-allotment is exercised in full). The Company will also
  pay the representative a separate capital market advisory fee of $
  2,500,000
  upon completion of the initial Business Combination. Additionally,
  the Company will pay the representative a cash fee equal to
  1.0
  %
  of the total consideration payable in the proposed Business Combination
  if the representative introduces the Company to the target business with which the Company completes a Business Combination; provided
  that the foregoing fee will not be paid prior to the date that is
  60
  days from the date of the prospectus for the Company's IPO,
  unless such payment would not be deemed underwriters' compensation in connection with this offering pursuant to FINRA Rule 5110.
  Right of First Refusal
  If the Company determines to pursue
  any equity, equity-linked, debt or mezzanine financing relating to or in connection with an initial Business Combination, then Northland
  shall have the right, but not the obligation, to act as book running manager, placement agent and/or arranger, as the case may be, in
  any and all such financing or financings. This right of first refusal extends from the date of the IPO until the earlier of the consummation
  of an initial Business Combination or the liquidation of the Trust Account if the Company fails to consummate a Business Combination during
  the required time period.
  Note 7 —
  Stockholders'
  Equity
  Preferred stock
  —The
  Company is authorized to issue
  1,000,000
  shares of preferred stock with a par value of $
  0.0001
  and with such designations, voting and
  other rights and preferences as may be determined from time to time by the Company's board of directors. As of June 30, 2021, there
  were
  no
  shares of preferred stock issued or outstanding.
  Common stock
  —The
  Company is authorized to issue
  100,000,000
  shares of common stock with a par value of $
  0.0001
  per share. At June 30, 2021, there were
  5,175,000
  shares of common stock issued and outstanding. On February 3, 2021, affiliates of the Sponsor paid $
  25,000
  , or approximately
  $
  0.006
  per share, to cover certain offering costs in consideration for
  4,312,500
  Founder Shares. On February 8, 2021, EarlyBirdCapital,
  Inc. and Northland purchased
  162,500
  and
  87,500
  representative shares, respectively, at an average purchase price of approximately $
  0.0001
  per share, or an aggregate purchase price of $
  25.00
  .
  13
  Table of Contents
  On May 29, 2021, Northland returned
  87,500
  shares of common stock to the Company, for no consideration, which were subsequently cancelled and on June 16, 2021, the Sponsor
  purchased an additional
  700,000
  shares of common stock at a purchase price of $
  0.006
  per share, resulting in the Sponsor holding an aggregate
  of
  5,012,500
  shares of common stock. On June 16, 2021, the Sponsor transferred
  50,000
  shares to each of its Chief Executive Officer and
  its President and
  35,000
  shares to each of its
  three
  independent directors. At June 30, 2021, the Founder Shares include an aggregate
  of up to
  675,000
  shares subject to forfeiture by the Sponsor to the extent that the underwriters' over-allotment option is not exercised
  in full or in part.
  Common stockholders of record
  are entitled to
  one vote for each share
  held on all matters to be voted on by stockholders. In connection with any vote held to approve
  the initial Business Combination, the Sponsor, as well as all of the Company's officers and directors, have agreed to vote their
  respective shares of common stock owned by them immediately prior to the IPO and any shares purchased in the IPO or following the IPO
  in the open market in favor of the proposed Business Combination.
  Warrants
  —Each
  whole warrant entitles the holder to purchase one share of common stock at a price of $
  11.50
  per share, subject to adjustment as discussed
  herein. The warrants will become exercisable
  30
  days after the completion of the Company's initial Business Combination.
  However, no warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the
  shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of common stock. Notwithstanding
  the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the public warrants is not effective
  within
  90
  days following the consummation of the initial Business Combination, warrant holders may, until such time as there is an effective
  registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise
  warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption
  is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless
  basis. In the event of such cashless exercise, each holder would pay the exercise price by surrendering the warrants for that number of
  shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the
  warrants, multiplied by the difference between the exercise price of the warrants and the "fair market value" (defined below)
  by (y) the fair market value. The "fair market value" for this purpose will mean the average reported last sale price of the
  shares of common stock for the
  5
  trading days ending on the trading day prior to the date of exercise. The warrants will expire on the
  fifth anniversary of the completion of an initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or
  liquidation.
  The Company may call the warrants for redemption, in whole and not in part, at a price of $
  0.01
  per warrant:
  •
  at any time after the warrants become exercisable,
  •
  upon not less than
  30
  days' prior written notice of redemption to each warrant holder
  •
  if, and only if, the reported last sale price of the common stock equals or exceeds $
  18.00
  per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations) for any
  20
  trading days within a
  30
  -trading day period commencing at any time after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and
  •
  if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants.
  14
  Table of Contents
  If the Company calls the warrants
  for redemption as described above, the Company's management will have the option to require all holders that wish to exercise warrants
  to do so on a "cashless basis." In such event, each holder would pay the exercise price by surrendering the warrants for that
  number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying
  the warrants, multiplied by the difference between the exercise price of the warrants and the "fair market value" (defined
  below) by (y) the fair market value. The "fair market value" for this purpose shall mean the average reported last sale price
  of the shares of common stock for the
  5
  trading days ending on the third trading day prior to the date on which the notice of redemption
  is sent to the holders of warrants.
  In addition, if (x) the Company
  issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of the
  initial Business Combination at an issue price or effective issue price of less than $
  9.20
  per share of common stock (with such issue
  price or effective issue price to be determined in good faith by the Company's board of directors, and in the case of any such issuance
  to the Sponsor, initial stockholders or their affiliates, without taking into account any founders' shares held by them prior to
  such issuance), (y) the aggregate gross proceeds from such issuances represent more than
  60
  %
  of the total equity proceeds, and interest
  thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination
  (net of redemptions), and (z) the Market Value is below $
  9.20
  per share, the exercise price of the warrants will be adjusted (to the nearest
  cent) to be equal to
  115
  %
  of the greater of (i) the Market Value or (ii) the price at which the Company issues the additional shares of
  common stock or equity-linked securities.
  Note 8 —
  Subsequent Events
  The Company evaluated subsequent events
  and transactions that occurred after the balance sheet date up to the date that the financial statements were available to be issued.
  The Company did not identify any subsequent events other than noted below that would have required adjustment or disclosure in these unaudited
  condensed financial statements.
  On July 23, 2021, the Sponsor purchased
  an additional
  1,200,000
  Founder Shares at a purchase price of $
  0.006
  per share, resulting in the Sponsor holding an aggregate of
  6,007,500
  shares of common stock and the Chief Executive Officer, President and independent directors holding an aggregate of
  205,000
  shares of
  common stock. At July 23, 2021, the Founder Shares include an aggregate of up to
  1,125,000
  shares subject to forfeiture by the Sponsor
  to the extent that the underwriters' over-allotment option is not exercised in full or in part.
  On August 17, 2021, the Company commenced
  the IPO of
  15,000,000
  units at $
  10.00
  per Unit. Simultaneously with the consummation of the IPO, the Company consummated the private placement
  of
  459,500
  Private Shares, at a price of $
  10.00
  per share for an aggregate purchase price of $
  4,595,000
  .
  After the close of the IPO, paying offering
  costs and having excess funds released from the trust account, on August 18, 2021, the Company had $
  1,163,587
  in cash available for working
  capital purposes.
  15
  Table of Contents
  Item 2. Management's Discussion and Analysis
  of Financial Condition and Results of Operations.
  References
  to "we", "us", "our" or the "Company" are to Armada Acquisition Corp. I, except where
  the context requires otherwise. The following discussion should be read in conjunction with our unaudited condensed financial statements
  and related notes thereto included elsewhere in this report.
  Cautionary Note
  Regarding Forward-Looking Statements
  This
  Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
  amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). We have based these forward-looking
  statements on our current expectations and projections about future events. These forward-looking statements are subject to known and
  unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements
  to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking
  statements. In some cases, you can identify forward-looking statements by terminology such as "may," "should,"
  "could," "would," "expect," "plan," "anticipate," "believe," "estimate,"
  "continue," or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy
  include, but are not limited to, those described in our other Securities and Exchange Commission ("SEC") filings.
  Overview
  We
  are a blank check company incorporated in Delaware on November 5, 2020, for the purpose of effecting a merger, stock exchange, asset acquisition,
  stock purchase, reorganization or other similar business combination with one or more businesses.
  On
  August 17, 2021, we consummated our IPO of 15,000,000 units, at $10.00 per unit, generating gross proceeds of $150 million.
  Simultaneously
  with the closing of the IPO, we consummated the private placement of 459,500 Private Shares for an aggregate purchase price of $4,595,000.
  Upon
  the closing of the IPO on August 17, 2021, $150,000,000 ($10.00 per unit) from the net proceeds of the sale of the units in the IPO and
  the sale of Private Shares were placed in the Trust Account.
  If
  we are unable to complete the initial Business Combination within the Combination Period, we will (i) cease all operations except for
  the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the
  outstanding public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account,
  including interest earned on the funds held in the Trust Account and not previously released to us but net of taxes payable ( and less
  up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will
  completely extinguish public stockholders' rights as stockholders (including the right to receive further liquidation distributions,
  if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of
  our remaining stockholders and our board of directors, liquidate and dissolve, subject (in the case of (ii) and (iii) above) to our obligations
  under Delaware law to provide for claims of creditors and the requirements of other applicable law.
  We cannot
  assure you that our plans to complete our initial business combination will be successful.
  Results of Operations
  Our
  entire activity since inception up to June 30, 2021 was our formation and preparation for our IPO. We will not generate any operating
  revenues until the closing and completion of our initial business combination, at the earliest.
  16
  Table of Contents
  For
  the three months ended June 30, 2021, we had net loss of $1,969, which consisted of formation and operating costs of $1,969.
  For
  the period from November 5, 2020 through June 30, 2021, we had net loss of $4,408, which consisted of formation and operating costs of
  $4,408.
  Liquidity and
  Capital Resources
  As
  of June 30, 2021, we had approximately $13,746 in our operating account and working capital deficit of $143,623 (excluding deferred offering
  costs).
  Our
  liquidity needs up to June 30, 2021 had been satisfied through advances from related parties to cover certain offering costs and formation
  expenses of $132,352 (see Note 5). In order to finance transaction costs in connection with a Business Combination, the Sponsor or an
  affiliate of the Sponsor or certain of our officers and directors may, but are not obligated to, provide us with Working Capital Loans,
  as defined below (see Note 5). As of June 30, 2021, there were no amounts outstanding under any Working Capital Loans.
  Subsequent
  to the period covered by this quarterly report on Form 10-Q (the "Quarterly Report"), we consummated our IPO (see Note 3)
  and the sales of Private Shares (See Note 4). Of the net proceeds from the IPO and the sales of Private Shares, $150,000,000 of cash was
  placed in the Trust Account and $1,605 of cash was held outside of the Trust Account and is available for the Company's working
  capital purposes. After the closing of the IPO, paying offering costs and having excess funds released from the trust account, on August
  18, 2021, the Company had $1,163,587 in cash available for working capital purposes.
  Based on
  the foregoing, management believes that we will have sufficient working capital and borrowing capacity to meet our needs through the earlier
  of the consummation of a Business Combination or one year from this filing. Over this time period, we will be using these funds for paying
  existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on
  prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring,
  negotiating and consummating the Business Combination.
  Critical Accounting
  Policies
  The
  preparation of these unaudited condensed financial statements in conformity with US GAAP requires management to make estimates and assumptions
  that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited
  condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those
  estimates. We have identified the following as our critical accounting policies:
  Deferred Offering
  Costs
  Deferred
  offering costs consisted of legal and accounting expenses incurred through the balance sheet date that were directly related to the IPO
  and that were charged to stockholders' equity upon the completion of the IPO on August 17, 2021.
  17
  Table of Contents
  Recent Accounting
  Pronouncements
  In August
  2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-06, Debt
  — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity's Own Equity
  (Subtopic 815-40) ("ASU 2020-06") to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current
  models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative
  scope exception guidance pertaining to equity classification of contracts in an entity's own equity. The new standard also introduces
  additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity's own equity.
  ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible
  instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption
  permitted beginning on January 1, 2021. We are currently assessing the impact, if any, that ASU 2020-06 would have on its financial position,
  results of operations or cash flows.
  Management
  does not believe that any recently issued, but not effective, accounting pronouncements, if currently adopted, would have a material effect
  on our unaudited condensed financial statements.
  Off-Balance Sheet Arrangements;
  Commitments and Contractual Obligations
  Registration
  Rights
  The holders
  of the Founder Shares issued and outstanding on the date of the IPO, as well as the holders of the representative shares, Private Shares
  and any shares the sponsor, officers, directors or their affiliates may issue in payment of Working Capital Loans made to us, will be
  entitled to registration rights pursuant to an agreement to be signed prior to or on the effective date of the IPO. The holders of a majority
  of these securities (other than the holders of the representative shares) are entitled to make up to two demands that we register such
  securities. The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three
  months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority of the Private
  Shares and shares issued to the Sponsor, officers, directors or their affiliates in payment of Working Capital Loans made to us can elect
  to exercise these registration rights at any time after we consummate a business combination. In addition, the holders have certain "piggy-back"
  registration rights with respect to registration statements filed subsequent to the consummation of a business combination. We will bear
  the expenses incurred in connection with the filing of any such registration statements.
  Underwriting Agreement
  We granted
  the underwriters a 45-day option from the date of the IPO to purchase up to an additional 2,250,000 units to cover over-allotments, if
  any.
  The underwriters
  were paid a cash underwriting discount of 1.0% of the gross proceeds of the IPO, or $1,500,000 (and are entitled to an additional $225,000
  of deferred underwriting commission payable at the time of an initial Business Combination if the underwriters' over-allotment is
  exercised in full).
  Item 3. Quantitative and Qualitative Disclosures
  About Market Risk
  Not required for smaller reporting
  companies.
  Item 4. Controls and Procedures
  Evaluation of Disclosure Controls and Procedures
  Disclosure controls and procedures
  are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized,
  and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated
  to our management, including our principal executive officer and principal financial officer or persons performing similar functions,
  as appropriate to allow timely decisions regarding required disclosure.
  18
  Table of Contents
  Under the supervision and with
  the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted
  an evaluation of the effectiveness of our disclosure controls and procedures as of June 30, 2021, as such term is defined in Rules 13a-15(e)
  and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial and accounting
  officer have concluded that as of June 30, 2021, our disclosure controls and procedures were effective.
  Changes in Internal Control over Financial Reporting
  During the most recently completed
  fiscal quarter ended June 30, 2021, there was no change in our internal control over financial reporting that has materially affected,
  or is reasonably likely to materially affect, our internal control over financial reporting.
  19
  Table of Contents
  PART II - OTHER INFORMATION
  Item 1. Legal Proceedings.
  None.
  Item 1A. Risk Factors.
  Not required
  for smaller reporting companies.
  Item 2. Unregistered Sales of Equity Securities
  and Use of Proceeds.
  Use of Proceeds
  On August 17, 2021, we consummated
  our IPO of 15,000,000 Units, each unit consisting of one share of common stock and one-half of one redeemable warrant of the Company,
  with each whole warrant entitling the holder thereof to purchase one share of common stock for $11.50 per share. The Units were sold at
  a price of $10.00 per unit, generating gross proceeds to the Company of $150,000,000. In connection with the IPO, the underwriters were
  granted a 45-day option from the date of the prospectus (the "Over-Allotment Option") to purchase up to 2,250,000 additional
  units (the "Over-Allotment Units") to cover over-allotments, if any. Northland acted as sole book-running manager of the IPO.
  The securities in the offering were registered under the Securities Act on a registration statement on Form S-1 (No. 333-257692), as amended.
  The SEC declared the registration statement effective on August 12, 2021.
  Simultaneously with the consummation
  of the IPO, we consummated the private placement of an aggregate of 459,500 Private Shares at a price of $10.00 per share, generating
  gross proceeds of $4,595,000. The issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities
  Act.
  The Private Shares are identical
  to the shares sold in the IPO, except that the Private Shares are not transferable, assignable or salable until 30 days after the completion
  of our initial business combination, subject to certain limited exceptions.
  We paid a total of $1,500,000
  in underwriting discounts and commissions and $1,842,968 for other offering costs related to the IPO. In addition, the underwriters agreed
  to defer up to $225,000 in underwriting discounts and commissions, in the event the underwriters' over-allotment option is exercised
  in full.
  Of the net proceeds from the IPO
  and the sales of the Private Shares, $150,000,000 of cash was placed in the Trust Account and $1,605 of cash was held outside of the Trust
  Account and is available for the Company's working capital purposes. After the closing of the IPO, paying offering costs and having
  excess funds released from the trust account, on August 18, 2021, the Company had $1,163,587 in cash available for working capital purposes.
  There
  has been no material change in the planned use of the proceeds from the IPO and sales of the Private Shares as is described in the Company's
  final prospectus related to the IPO.
  Item 3. Defaults Upon Senior Securities.
  None.
  Item 4. Mine Safety Disclosures.
  Not Applicable.
  Item 5. Other Information.
  None.
  20
  Table of Contents
  Item 6. Exhibits
  The following exhibits are filed
  as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
  No.
  Description of Exhibit
  1.1
  Underwriting Agreement, dated August 12, 2021, by and between the Company and Northland, as representative of the several underwriters.
  (1)
  3.1
  Second Amended and Restated Certificate of Incorporation.
  (1)
  3.2
  Bylaws.
  (2)
  4.1
  Warrant Agreement, dated August 12, 2021, by and between the Company and Continental Stock Transfer & Trust Company ("CST"), as warrant agent.
  (1)
  10.1
  Investment Management Trust Agreement, dated August 12, 2021, by and between the Company and CST, as trustee.
  (1)
  10.2
  Registration Rights Agreement, dated August 12, 2021, by and between the Company, its officers, its directors, Armada Sponsor LLC (the "Sponsor") and EarlyBirdCapital, Inc.
  (1)
  10.3
  Private Placement Shares Purchase Agreement, dated August 12, 2021, by and between the Company and the Sponsor.
  (1)
  10.4
  Letter Agreement, dated August 12, 2021, by and among the Company, its officers, its directors, and the Sponsor.
  (1)
  10.5
  Administrative Services Agreement, dated August 12, 2021, by and between the Company and the Sponsor.
  (1)
  10.6
  Stock Escrow Agreement, dated August 12, 2021, by and between the Company, its directors, its officers, the Sponsor and CST.
  (1)
  10.7
  Business Combination Marketing Agreement, dated August 12, 2021, by and between the Company
      and Northland.
  (1)
  31.1*
  Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
  31.2*
  Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
  32.1**
  Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  32.2**
  Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  101.INS*
  XBRL Instance Document
  101.CAL*
  XBRL Taxonomy Extension Calculation Linkbase Document
  101.SCH*
  XBRL Taxonomy Extension Schema Document
  101.DEF*
  XBRL Taxonomy Extension Definition Linkbase Document
  101.LAB*
  XBRL Taxonomy Extension Labels Linkbase Document
  101.PRE*
  XBRL Taxonomy Extension Presentation Linkbase Document
  104*
  Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).
  *
  Filed herewith.
  **
  Furnished herewith.
  (1)
  Previously filed as an exhibit to our Current Report on Form 8-K filed on August 18, 2021 and incorporated by reference herein.
  (2)
  Previously filed as an exhibit to our Registration Statement on Form S-1 on July 2, 2021 and incorporated by reference herein.
  21
  Table of Contents
  SIGNATURES
  In accordance with the requirements
  of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
  ARMADA ACQUISITION CORP. I
  Date: September 27, 2021
  By:
  /s/ Stephen P. Herbert
  Name:
  Stephen P. Herbert
  Title:
  Chief Executive Officer
  (Principal Executive Officer)
  Date: September 27, 2021
  By:
  /s/ Douglas M. Lurio
  Name:
  Douglas M. Lurio
  Title:
  President
  (Principal Accounting and Financial Officer)